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ABSTRACT 
Sorcin, a penta-EF hand Ca2+-binding protein, is known to interact with cardiac 
ryanodine receptors type 2 (RyR2) and other Ca2+ regulatory proteins, including the L-
type Ca2+ channel (LTCC), Na+-Ca2+ exchanger (NCX), and sarcoplasmic/endoplasmic 
reticulum-Ca2+-ATPase (SERCA). However, sorcin’s influence on cardiac excitation-
contraction coupling and its role in the development of cardiac malfunctions are not 
known. In this study, we generated a sorcin knockout (sorcin KO) mouse model to 
examine the role of sorcin in intracellular Ca2+ handling and its potential role in disease 
pathogenesis. Sorcin KO mice had no cardiac structural alterations, but had a shorter 
life span than WT. Chronic stress, which was induced by transverse aortic constriction, 
significantly decreased the survival rate of sorcin KO mice. Sorcin KO cardiomyocytes 
presented a high incidence of spontaneous sarcoplasmic reticulum (SR) Ca2+ release 
events under isoproterenol stimulation. As the result, isoproterenol-stimulated young (1-
month-old) sorcin KO hearts/cardiomyocytes presented ventricular arrhythmia episodes, 
depleted SR Ca2+, and impaired contractility. The impaired contractility, however, was 
rescued in adult (6-month-old) sorcin KO hearts. Sorcin KO hearts of adult, but not 
young mice developed overexpression of L-type Ca2+ channel and Na+-Ca2+ exchanger, 
which enhanced ICa and INCX. Although the electrophysiological remodeling of ICa and 
INCX helped to retain SR Ca
2+ load and heart contractility, it provided favorable substrate 
for DADs and EADs, leading to sustained ventricular arrhythmia, cardiac arrest, and 
sudden death in adult sorcin KO mice. Our study demonstrates that the loss of sorcin 
would impair contractility and further trigger lethal arrhythmias due to generalized Ca2+ 
disturbances and electrophysiological remodeling. The results evidenced the 
detrimental effect of sorcin’s absence in the development of cardiac dysfunction.
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CHAPTER I 
Introduction: Cardiac excitation-contraction coupling  
1.1 Ultrastructure of cardiomyocytes 
The heart is a muscular organ which pumps blood throughout the body to meet the 
metabolic requirements of cells. In humans and mammals, the heart is divided into four 
chambers: upper left atria, upper right atria, lower left ventricle, and lower right ventricle.  
Through contraction, the heart pumps blood to the systemic circuit to provide the body 
oxygen and nutrients (1). 
Arranging in organized layers, ventricular cardiomyocytes constitute the two lower 
ventricles of the heart.  Ventricular cardiomyocytes are highly specialized, rod-shaped 
cells, typically 100~150 m long and 20~35 m in diameter. For an efficient coupling of 
electrical excitation and contraction, a delicate sarcolemma ultrastructural organization 
is developed in ventricular cardiomyocytes. Transverse tubules (T-tubules), which are 
finger-like membrane structures, penetrate deep into the cell as an extension of the 
surface plasma membrane (surface sarcolemma). This folding structure makes up 21-
33% of the total sarcolemmal area (2, 3), thus greatly increasing the ratio of plasma 
membrane area to cell mass. T-tubules provide scaffold structures for anchoring of ion 
channels. The L-type Ca2+ channel, a voltage-gated channel that plays an important role 
in cardiomyocyte contraction, is highly concentrated in T-tubules. Formamide-induced 
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detubulation of rat cardiomyocytes leads to a 75% decrease of L-type Ca2+ current (ICa) 
(4). Considering the ratio of T-tubules to surface sarcolemma (21-33% of the total 
sarcolemmal area), it can be inferred that Ca2+ channel density in the T-tubule is ~9 
times higher than that in the surface sarcolemma. Therefore, the structural 
specialization of T-tubules makes it a Ca2+ entry site of cardiomyocytes (Fig. 1A). 
Besides T-tubules, the sarcolemma also forms flask-shape invaginations called 
caveolae (5). Varieties of signaling molecules, including scaffolding protein caveolin-3, 
are enriched in caveolae. Therefore, caveolae serves as a place where incoming and 
outgoing messengers meet (6). 
Another set of intracellular membrane system, the sarcoplasmic reticulum (SR), is 
present in the cytosol of cardiomyocyte. Serving as a “Ca2+ warehouse”, the SR stores 
Ca2+ and provides majority of Ca2+ needed for myofilament contraction during 
excitation-contraction coupling (e-c coupling). According to differences in function, 
shape and location, SR can be classified into longitudinal SR and junctional SR. 
Longitudinal SR distributes along cardiomyocyte, forming a network that wraps around 
myofibrils. Highly expressed in longitudinal SR are SR Ca2+-ATPase pumps (SERCA), 
which pump intracellular cytosolic Ca2+ ([Ca2+]i) back to the SR. Junctional SR, in 
contrast, localizes close to the sarcolemma. The enlarged terminal of the junctional SR, 
named subsarcolemmal cisterna, forms a junction with either the surface sarcolemmal 
or T-tubule as a dyad. Ryanodine receptors type 2 (RyR2s), the Ca2+-gated SR Ca2+ 
release channel, are highly expressed in the junctional SR (Fig. 1B) as organized 
clusters. The narrow space between the surface sarcolemma and junctional SR (less 
than 15 nm) forms a functional correlation between LTCC and RyR2s during e-c 
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coupling. In cardiomyocytes, this arrangement usually comes with a stoichiometry of 1 
LTCC to 4~10 RyR2s [6].  
1.2 Ca2+-induced Ca2+ release, Ca2+ sparks, and Ca2+ waves  
 The structure of the dyad favors an intimate communication between LTCC and RyR2s, 
the two key ion channels involved in Ca2+-induced Ca2+ release.  LTCC consists of four 
pore-forming 1-subunits and ,, ,accessory subunits (7). The channel is named 
as L-type due to its Large conductance (~25 pS in 110 mM Ba2+, compared with ~8 pS 
of T-type Ca2+ channel) and Long lasting activation status (8). ICa is activated at the 
membrane potential of -40 mV and reaches a peak at 0~10 mV. At more positive 
membrane potentials, the open probability (Po) of LTCC increases but the Ca
2+ driving 
force decreases so ICa is reduced. Therefore, ICa presents a bell-shaped current-voltage 
relationship (I-V curve). Under the sustained membrane depolarization, ICa gradually 
decreases due to the Ca2+-and voltage-dependent inactivation. The Ca2+ entry through 
LTCC and SR Ca2+ release can greatly accelerate the inactivation of ICa, suggesting 
Ca2+-dependent inactivation is much faster than voltage-dependent inactivation (9). 
Facing the LTCC in the dyad structure are RyR2s, the Ca2+-gated SR Ca2+ release 
channels. The channel gained its name due to its affinity for the plant alkaloid ryanodine, 
which has excitatory effect on RyR2s at concentration lower than 1 M, but inhibitory 
effect at concentration higher than 100 M (10, 11). As the largest known ion channel, 
RyR2 is a homotetramer with each subunit at the molecular size of 560 kDa. In electron 
micrographs, the RyR2 presents mushroom-shaped structure. The four S6 
transmembrane segments of carboxyl-terminus form the ion conducting pore, allowing 
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Ca2+ to permeate from the SR lumen to the cytosol. The nine domains of each protomer 
in cytosol side form a superhelical assembly, which interacts with the neighboring super 
spiral to form the cytosolic region of RyR2 (12-14) (Fig. 2). Varieties of ligands, including 
Ca2+, protein kinase A, Ca2+/calmodulin-dependent protein kinase II, FKBP 12.6, S100A, 
and sorcin, bind to the cytosolic region of RyR2 to modulate the gating of the channel. 
Among those, Ca2+ is the most potent regulator by binding to the cytosolic or lumen side 
of RyR2. The RyR2 activity vs. Ca2+ concentration plot is bell-shaped: Ca2+ activates 
RyR2s at the range of 0.1 to 10 M but inactivates RyR2s at the concentration higher 
than 100 M. The affinity and cooperativity of Ca2+ binding to RyR2 sites are greatly 
influenced by the posttranslational modification of the channel (phosphorylation, 
oxidation, and nitrosylation) and the presence of other modulators (Mg2+, ATP, H+). For 
complete RyR2 inactivation, a supraphysiologic Ca2+ concentration (1~3 mM) is required 
(15-17), which makes the [Ca2+]i-dependent inactivation of RyR2 unlikely be a major 
mechanism for the termination of e-c coupling. 
In each heartbeat, the action potential propagates to the T-tubules of ventricular 
cardiomyocytes and activates the voltage-gated LTCCs. The Ca2+ influx through the 
LTCCs raises the dyad [Ca2+] to a level high enough to activate at least one of RyR2s in 
the cluster. The release of Ca2+ through activated RyR2 further recruits neighboring 
RyR2s, leading to a local Ca2+ release event. Synchronized by the action potential, local 
Ca2+ release events turn to a global massive Ca2+ release from SR, which is observed 
as an overall Ca2+ transient. This Ca2+-induced Ca2+ release process dramatically 
increases the whole cell [Ca2+]i from 100 nM to ~1 M, and leads to contraction of 
myofilaments.  
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The local Ca2+ release can also happen spontaneously without ICa. In an unstimulated 
cardiomyocyte loaded with the fluorescent Ca2+ indicator Fluo-4, local Ca2+ releases can 
be observed as “Ca2+ sparks” (Fig. 3A-B). The diameter of a Ca2+ spark is confined to 
~2.0 m. The fluorescence intensity of a spark peaks to ~2 fold of background level 
within 10 ms, and gradually decays within 20 ms (Fig. 3C). Due to the stochastic 
opening of RyR2s, Ca2+ sparks appear randomly in time and space. The frequency of 
Ca2+ sparks is positively correlated to RyR2-activity, thus the elevation of [Ca2+]i and SR 
lumen Ca2+ ([Ca2+]SR), which increase RyR2 activity, significantly increase the Ca
2+ 
spark frequency. Some RyR2 gain-of function mutations (e.g. V2475F (18), R4496C 
(19), R176Q (20)) could also significantly increase RyR2’s sensitivity to cytosol and 
luminal Ca2+, leading to increased Ca2+ sparks in the resting state.  
In a normal situation, locally released Ca2+ in resting cell quickly dissipates in the 
cytosol, so Ca2+ sparks do not trigger cell-wide Ca2+ wave. However, when RyR2s are 
hyper-activated due to elevated [Ca2+]i, [Ca
2+]SR, or due to gain of function mutations, 
Ca2+ spreads to the neighboring dyad and is more likely to recruit more RyR2s. Thus, 
the spatially discrete Ca2+ spark develops into a arrhythmogenic Ca2+ wave that can 
propagate along the cell (Fig. 3D). 
1.3 Termination of Ca2+-induced Ca2+ release and the removal of [Ca2+]i 
Theoretically, Ca2+-induced Ca2+ release is a self-regenerative process, in which 
increased [Ca2+]i keeps stimulating RyR2s to allow more Ca
2+ release. However, under 
physiological conditions, Ca2+ release during in e-c coupling is quickly terminated, 
suggesting mechanisms exist to stop the positive feedback. Fabiato et al. propose that 
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besides the Ca2+ activation site, a high-affinity but slow-action Ca2+ inactivation site 
exists in RyR2 (21). While a fast Ca2+ stimulus quickly evokes a burst of RyR2-activity, 
Ca2+ also gradually binds to the inactivation site, leading to a slow inactivation of the 
channel. The refractory period of RyR2s prevents further SR Ca2+ release until Ca2+ is 
removed from the dyad. The theory of Ca2+-dependent inactivation, although straight 
forward and elegant, is not well supported by experiment results, as RyR2s under 
constitutive Ca2+ stimulation are able to be reactivated  (22). Moreover, single channel 
recording shows that [Ca2+]i needs to be 1~3 mM to inactivate RyR2s, which is hard to 
be reached during e-c coupling.  
Another mechanism for termination of Ca2+-induced Ca2+ release is the depletion of SR 
Ca2+. It has been demonstrated that Ca2+ release through RyR2s is terminated once SR 
Ca2+ drops to ~50% of its total (23, 24), although the underlying mechanism is unknown. 
While some research suggests luminal [Ca2+] directly regulates RyR2 inactivation (25, 
26), other work suggests that calsequestrin, a luminal Ca2+ binding protein, is required 
(27, 28).  Besides these mechanisms, some Ca2+-regulatory proteins, such as sorcin, 
also play an active role in the termination of Ca2+-induced Ca2+ release. Details will be 
discussed later in the dissertation.  
After Ca2+-induced Ca2+ release, Ca2+ must be eliminated to drive cell relaxation. Four 
transporters work synchronously to bring [Ca2+]i down: SR Ca
2+ ATPase (SERCA), Na+-
Ca2+ exchanger (NCX), Ca2+ ATPase, and mitochondrial Ca2+ uniporter. Highly 
expressed in longitudinal SR membrane, SERCA pumps [Ca2+]i back to the SR at the 
cost of ATP hydrolysis. The rate of Ca2+ pumping by SERCA is regulated by the protein 
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phospholamban (PLN), which exerts an inhibitory effect on SERCA function. When 
under -adrenergic stimulation, phosphorylated PLN is dissociated from SERCA so 
SERCA pumps at a higher rate to meet the requirement of Ca2+ homeostasis. NCX is 
an antiporter protein driven by the electrochemical gradient across the cell membrane. 
When the membrane potential (Vm) is negative to the reversal potential of NCX (ENCX= 
ENCX=3ENa-2ECa, which is ~-60 mV in resting state), NCX works in the forward mode to 
pump 1 Ca2+ out for 3 Na+ in. In rabbit (and in human) ventricular cardiomyocytes, the 
contribution of SERCA, NCX, Ca2+-ATPase and mitochondrial Ca2+ uniporter to Ca2+ 
removal is 70%, 28%, 1% and 1% respectively. In rat and mice ventricular 
cardiomyocytes, the ratio is 92%, 7%, 0.5%, and 0.5%. In summary, SERCA and NCX 
play predominant roles in Ca2+ removal at the end stage of e-c coupling (29). 
1.4 Excitation-contraction coupling 
The contraction of myofilaments is initiated by the elevation of [Ca2+]i.  At low [Ca
2+]i, the 
binding site between actin and cross-bridge of myosin is blocked by troponin and 
tropomyosin of thin myofilament, so the muscle fiber is in a resting state. Once SR Ca2+ 
release is triggered, the binding of Ca2+ to the troponin C in the thin filament causes 
conformational changes that dissociate troponin from actin and adjust the position of 
tropomyosin to expose a site on actin which can strongly bind the cross-bridge of 
myosin. Strong cross-bridge binding to actin uses energy from ATP hydrolysis to initiate 
a power stroke, which generates a force and/or shortening via sliding of the thin filament 
within the sarcomere.  
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In summary, in each heartbeat, excitatory membrane depolarization spreads from the 
SA node to the ventricular cardiomyocytes. During membrane depolarization, the 
opening of voltage-gated Ca2+ channels allows the influx of a small amount of Ca2+, 
which triggers massive SR Ca2+ release to the cytosol. By binding to the troponin C of 
the myofilament, free Ca2+ triggers the contraction of the myofilament. This process, 
called e-c coupling, converts the excitatory membrane depolarization originated from 
the SA node to the mechanical contraction of the cardiomyocyte (29). Because the 
contractility of the myofilament is sensitive to the concentration of surrounding [Ca2+]i, 
synchronized SR Ca2+ release during e-c coupling is required for efficient ventricular 
contraction.  
1.5 Regulation of excitation-contraction coupling by sympathetic activation 
During exercise or under emotional stress, the heart beats at a faster rate and strength 
to meet the increased metabolic requirements of the body. This process is mediated by 
the sympathetic stimulation-activated-adrenergic pathway. During -adrenergic 
stimulation, catecholamines (norepinephrine, epinephrine) released from sympathetic 
nerves and the adrenal medulla bind to-adrenergic receptors in cardiomyocytes to 
trigger protein kinase A (PKA)-mediated phosphorylation of  LTCC, PLN, RyR2, 
troponin I, and myosin binding protein C. The phosphorylation of LTCC significantly 
increases ICa, which increases Ca
2+ entry during e-c coupling. Meanwhile, 
phosphorylation of PLN relieves the protein’s inhibitory effect on SERCA, thus 
increasing SR Ca2+ uptake rate and SR Ca2+ content. The increased ICa and SR Ca
2+ 
load greatly enhances Ca2+ transient amplitudes, exerting an inotropic effect on the 
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heart (29). The phosphorylation of troponin I accelerates the dissociation of Ca2+ from 
myofilament, exerting a lusitropic effect on heart.  
RyR2 is also one of target proteins phosphorylated under -adrenergic stimulation. It 
has been reported that -adrenergic stimulation could accelerate and synchronize 
RyR2s’ response to opening of a single LTCC (30). At least three phosphorylation sites 
of RyR2, Serine 2808 (S2808), Serine 2814 (S2814) and Serine 2030 (S2030), have 
been identified. S2814 is exclusively phosphorylated by Ca2+/calmodulin-dependent 
protein kinase II (CaMKII), which is another downstream kinase activated by the 
Ca2+/Calmodulin complex in the-adrenergic signaling pathway. S2030 is exclusively 
phosphorylated by PKA, and S2808 can be phosphorylated by both PKA and CaMKII. 
During -adrenergic stimulation, RyR2s response to extrinsic cues (enhanced ICa and 
SR Ca2+) releases more Ca2+ into the cytosol.  However, whether the direct 
phosphorylation of RyR2s will bring intrinsic changes to the channel gating is highly 
controversial. Marks et al. propose that exclusive PKA-phosphorylation at S2808 of 
RyR2 will dissociate the RyR2 stabilizer, named FKBP 12.6, from RyR2, rendering 
RyR2 hyperactive during -adrenergic stimulation. In later studies, they report that mice 
harboring a non-phosphorylated S2808A mutation have blunted “fight or flight” 
responses to-adrenergic stimulation, and are protected from heart failure and 
arrhythmias due to the prevention of diastolic SR Ca2+ leak (31-34). However, several 
laboratories failed to reproduce key experiments underlying this hypothesis by showing 
S2808A mice present a preserved response to -adrenergic stimulation and a normal 
progression to heart failure as WT (35-37). In fact, single channel recording finds that 
while PKA stimulation increases the responsiveness of RyR2 to [Ca2+]i, it accelerates 
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adaptation of RyR2 and brings the channel to a lower steady state (38). In the cellular 
setting, the effect of RyR2 phosphorylation is reflected as an increased rising rate of the 
Ca2+ transient in response to a given Ca2+ entry (ICa) and SR Ca
2+ load. Ca2+ transient 
amplitude, however, won’t change (39). In contrast to Marks’ hypothesis, Shannon and 
Bers propose that CaMKII, not PKA, mediates-adrenergic stimulation-mediated SR 
Ca2+ leak (40, 41). Based on these facts, Valdivia proposes a “multi-phosphorylation 
site model”. In this model, residues from 2804 to 2814 constitute a “phosphorylation hot 
spot” of RyR2, which is targeted by several kinases (PKA, CaMKII, PKG). The change 
of RyR2 gating is a combined effect of kinases on phospho sites in the hot spot, while 
the phosphorylation of a single residue has little influence on the channel gating 
property (42).  Due to the divergent observations and controversy, more work is needed 
to illustrate the role of RyR2 phosphorylation in Ca2+ homeostasis. 
1.6 Cardiomyocyte Ca2+ handles heart rhythm and contractility 
Because myofilament contraction could happen as long as there are sufficient Ca2+ and 
ATP, the heart rhythm and contractility are directly influenced by the timing and amount 
of Ca2+ released from SR. When a spontaneous Ca2+ release appears between two 
normal beatings, extra contraction as well as decreased contractility will appear due to 
Ca2+ turbulence.  
Role of Ca2+ in heart rhythm 
Under normal conditions, SR Ca2+ release is precisely controlled by the rhythm of 
the sinus node. However, in some pathological conditions, spontaneous SR Ca2+ 
releases events (Ca2+ sparks and Ca2+ waves) could happen without an action 
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potential due to RyR2-hyperactivity and/or SR Ca2+ overload. An extra action 
potential, named delayed afterdepolarization (DAD), or early afterdepolarization 
(EAD), could be triggered by spontaneous Ca2+ release events. DAD happens 
when the cell is in a resting condition. The elevated diastolic [Ca2+]i drives NCX to 
extrude Ca2+ out at the expense of letting 3 Na+. The stoichiometry of the Ca2+-
Na+ exchange (1:3) generates an inward current, which would depolarize the 
membrane potential and may further trigger an extra action potential once Vm 
reaches the threshold (43). EAD is more likely to appear in a cell with prolonged 
action potential duration. In the plateau phase of the action potential, the 
reactivation of ICa and INCX can depolarize the membrane potential and lead to 
another upstroke before the cell completely repolarizes (44) (Fig. 3E). Both DAD 
and EAD are able to trigger a synchronized Ca2+ wave, thus triggering an extra 
contraction between two normal beatings (Fig. 3D). The repetition of this altered 
focal Ca2+ turbulence could further lead to tachycardia and ventricular 
arrhythmias. 
A typical example of Ca2+-mishandling triggered arrhythmia is catecholaminergic 
polymorphic ventricular tachycardia (CPVT), which is an autosomal-dominant 
inherited cardiac syndrome. Patients with CPVT present no structural remodeling 
in the heart and have normal heart function in resting state. However when under 
physical exercise or dramatic emotional stress, patients suffer from polymorphic 
ventricular arrhythmias, which could develop into cardiac arrest and sudden 
death. Spontaneous SR Ca2+ release in diastole is considered to be the 
underlying mechanism. As referred above, in cardiomyocytes of CPVT patients, 
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the Ca2+-activated INCX depolarizes Vm to the threshold to trigger an 
arrhythmogenic DAD. More than 160 mutations in RyR2, the RyR2 encoding 
gene, are known to be associated with CPVT. An underlying hypothesis for the 
hyperactivity of mutant RyR2s (RyR2 gain-of function) includes dissociation of 
the RyR2 stabilizer FKBP 12.6 (45, 46), a decreased threshold for store-overload 
induced calcium release (SOICR) (26, 43, 47), and defective interaction between 
RyR2 interdomains (48). Mutations in CSQ2, the calsequestrin encoding gene, 
could also generate CPVT. Calsequestrin is a luminal Ca2+-binding protein in the 
SR. By forming a complex with triadin, junctin and RyR2, calsequestrin helps to 
inhibit RyR2 activity when SR Ca2+ concentration is low. When SR Ca2+ 
increases, polymerized calsequestrin dissociates from the complex and 
effectively binds to SR Ca2+ as a Ca2+ buffer. Mutations in CSQ2 could abolish 
calsequestrin’s inhibitory effect on RyR2s during diastole, and reduces its Ca2+ 
binding and buffering capacity. The higher RyR2 activity and SR Ca2+ overload, 
then, would trigger SOICR and arrhythmias in CSQ2 mutant cardiomyocytes (49, 
50). 
Role of Ca2+ handling in heart failure 
As the concentration of [Ca2+]i surrounding the myofilament directly influences the 
contractility, [Ca2+]i mishandling could lead to the syndrome of heart failure. Heart 
failure is a pathological condition in which the heart contractility is impaired thus 
cannot pump enough blood throughout the body to meet metabolic requirements. 
Research has found that there are increased subconductance openings of 
RyR2s and decreased SERCA function in heart failure cardiomyocytes, which 
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deplete SR Ca2+ and  blunt Ca2+ transients in e-c coupling (51, 52).  Marks’ group 
proposes that the RyR2-S2808 phosphorylation is increased in the failing heart, 
as the heart is usually under chronic -adrenergic stress to maintain efficiency 
and competence. The PKA-mediated RyR2 phosphorylation at S2808, however, 
could dissociate FKBP12.6 from RyR2, thus increasing the SR Ca2+ leak and 
further deteriorating heart function (33, 53, 54). Wehren’s group also proposes 
that the prevention of CaMK II phosphorylation at S2814 has a protective effect 
on pressure overload-induced heart failure (55). Although the hypothetical 
relationship between heart failure and RyR2 phosphorylation is straight forward 
and attractive, some key tenets cannot be confirmed by other groups (42, 52, 56, 
57).  
Besides Ca2+’s direct influence on heart contractility, Ca2+ mishandling also 
activates two cardiomyopathy-related signaling pathways, calcineurin-NFAT and 
CaMK-MEF2 pathway. The downstream gene transcription results in maladaptive 
structural remodeling, which eventually develops into hypertrophy and congestive 
heart failure (58, 59). 
1.7 Summary 
The ultrastructure of T-tubules provides great advantage for cardiomyocytes to convert 
the excitatory membrane depolarization to Ca2+-triggered myofilament contraction. At 
the upstroke of the action potential, the opening of voltage-gated Ca2+ channels allows 
influx of a small amount of Ca2+, which triggers massive SR Ca2+ release into the 
cytosol. By binding to troponin C in the myofilament, free Ca2+ triggers myofilament 
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contraction. This process, called e-c coupling, converts the excitatory membrane 
depolarization originated from the sinus node to mechanical contraction by the 
cardiomyocyte. After contraction, the majority of [Ca2+]i is either extruded out of cell by 
NCX, or recycled back to SR by SERCA. 
Ca2+ homeostasis determines heart rhythm and contractility. The -adrenergic 
stimulation exerts positive inotropic and lusitropic effects on ventricular cardiomyocytes 
by enhancing Ca2+ homeostasis. Ca2+ mishandling could result in arrhythmias and heart 
failure. 
As Ca2+ plays a crucial role in heart function, the tuning of Ca2+ release must be 
precisely regulated by varieties of proteins, such as FKBP 12.6 (60, 61), S100A1 (62, 
63), calmodulin (64), and calsequestrin (27, 28). In this project, I focus on one of Ca2+ 
regulatory proteins, named sorcin. 
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Figure 1.Ultrastructure of mammalian cardiac muscle (8) (65). (A) Surface sarcolemma, T-tubule, and 
sarcoplasmic reticulum. (B) Dyad formed by a T-tubule and a cisterna of junctional SR.  
 
 
 
 
 
 
 
 
 
 
Figure 2. The electron microscopy map of closed RyR2 from porcine heart at resolution of 4.4 Å 
(12, 66). (A) Top view of closed RyR2. (B) Side view of RyR2. (C) Domain organization of a RyR2 
protomer. NTD: amino-terminal domain; SPRY: SPla and the RYanodine Receptor domain; HD: helical 
domain; CD: central domain; PFD: pore-forming domain. The figure is the courtesy of Francisco J. 
Alvarado and is drawn based on Peng, W., et al., Structural basis for the gating mechanism of the type 2 
ryanodine receptor RyR2. Science, 2016. 354(6310). 
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Figure 3. Ca
2+
 sparks, spontaneous Ca
2+
 waves DADs and EADs. (A) Ca
2+
 sparks observed in a fluo-4 
AM loaded cardiomyocyte by confocal microscopy. A line across the cell is chosen to observe Ca
2+
 
activities.  (B) Ca
2+
 sparks observed in line scan mode. A line is chosen across the cardiomyocyte (shown 
in figure A) and the Ca
2+
 activity across the line is observed. (C) 3D-plot of a representative Ca
2+
 spark. 
(D) Spontaneous Ca
2+
 waves and delayed afterdepolarizations observed in a cardiomyocyte with RyR2 
CPVT mutation (R4496C+/-). The cell is under current clamp mode and is stimulated by current injection 
at 1Hz for 20 times (shown as arrow) to trigger action potentials and Ca
2+
 transients. Upper panel: action 
potential; middle panel: simultaneous fluorescent recording of Ca
2+
 transient; under panel: line plot of 
Ca
2+
 transient. Square a: a spontaneous Ca
2+
 wave triggers an extra action potential when the cell is fully 
repolarized (delayed afterdepolarization) (see section 1.6.1). Square b, c: spontaneous Ca
2+
 waves that 
fail to trigger action potentials during or after pacing. (E) The mechanisms for the generation of DAD and 
EAD (67). DAD happens when the cell is in resting condition. The elevated diastolic [Ca
2+
]i drives NCX to 
E 
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extrude Ca
2+
 out at the expense of letting Na
+
 in with a stoichiometry of 1:3, thus generating an inward 
current. The inward current depolarizes membrane potential and could trigger an extra action potential 
once Vm reaches to the threshold. EAD is more likely to appear in cell with prolonged action potential 
duration. In the plateau phase of action potential, the reactivation of ICa and INCX can depolarize 
membrane potential and lead to another upstroke before the cell completely repolarized.  
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CHAPTER II 
Sorcin, a Ca2+ regulatory protein in cardiomyocytes 
2.1 Introduction 
Sorcin (soluble resistance-related calcium-binding protein) acquires its name because it 
is found to be overexpressed in several chemoresistant cell lines, and could be used as 
a biomarker of multidrug-resistance in several tumors (68-73). Silencing of sorcin by 
oligonucleotides in tumor cells could increase cell sensitivity to antitumor-drugs, 
suggesting sorcin is a promising target for reversing tumor multidrug-resistance (74, 75). 
However, further studies find a broad expression of sorcin in cardiomyocytes, neurons, 
pancreatic cells, and vascular smooth muscle (76-79), clearly transcending its role in 
multi-drug resistance. The following part will focus on sorcin’s effect on cardiomyocytes 
and heart function. Sorcin’s structure, target proteins and role in heart function will be 
reviewed in this chapter.  
2.2 Structural basis of Ca2+-dependent activation of sorcin 
Sorcin is a 21.6 kDa protein that belongs to the penta-EF hand protein family (72, 80-
82). Two domains, a glycine-rich N-terminal domain and a C-terminal Ca2+ binding 
domain, constitute the sorcin structure (80, 83).  The Ca2+ binding domain is endowed 
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with five EF hands organized by eight -helices (A-H). In physiological condition, sorcin 
forms a homodimer structure through interaction of EF4-5. EF1-3, which are more 
flexible than EF4-5, have high Ca2+ binding affinity (KdCa ~1 M) (84). The binding of 
Ca2+ to EF3 leads to the movement of three binding ligands, Asp113, Asp115 and 
Ser117, towards the E helix. As the result, the rigid and long D helix that connects EF2 
and 3 undergoes a 21° shift away from the E-helix. EF1 and EF3 are widely opened, 
while EF2 displays minor movement (Fig. 4).  
The opening of EF1 and EF3 upon Ca2+ binding makes an increase of 33% of solvent-
accessible surface areas. The exposure of hydrophobic residues, including Tyr67, 
Ser80, Met81, Met86, Ile110, Arg116, Gly118, Ser143 and Ser197, enables sorcin to 
translocate from cytosol to cellular membranes. In accordance with the structural 
character, western blot of sorcin in permeabilized mouse cardiomyocytes shows that the 
percentage of membrane-bound sorcin significantly increases with the elevation of Ca2+ 
(ED50=204 M Ca
2+). Three hydrophobic pockets located in EF1 and EF3 (pocket 1: 
His108, Met132; pocket 2: Met81, Val101, Trp105, Val164; pocket 3: Ala26, Phe27, 
Pro28, Pro34, Leu35, Tyr36, Gly37, Tyr38, Ser61, Trp99) play important roles in 
mediating interactions between sorcin and its target proteins (81, 85). 
2.3 Target proteins of sorcin in cardiomyocytes 
In cardiomyocytes, sorcin is localized at z-lines that are in close proximity to T-tubules, 
which enables it to be regulated by the dynamic change of [Ca2+]i during e-c coupling 
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(86, 87). Under resting conditions, [Ca2+]i is at ~100 nM so most of sorcin is soluble in 
the cytosol close to T-tubules and is inactive. When Ca2+-induced Ca2+ release is 
triggered, local [Ca2+]i  at dyad could theoretically rise to ~100 M, leading to the binding 
of free Ca2+ to sorcin. The exposure of hydrophobic structure makes sorcin to 
translocate from cytosol to membrane-bond ion channels, pumps and exchangers, 
including RyR2, SERCA, NCX, and LTCC. 
Sorcin’s effect on RyR2 
In 1995, Meyers et al. firstly found sorcin is localized at SR of cardiomyocytes. 
The immunoprecipitation of sorcin pulls down a >500 kDa protein band, which is 
indistinguishable from the 565 kDa RyR2. The mutation of Trp 105 (W105G) at 
D-helix of sorcin impairs the binding of sorcin to RyR2 (85), which further 
confirms the direct interaction of sorcin to RyR2 in cardiomyocytes (76). In single 
channel recording of a swine cardiac RyR2, recombinant sorcin added in the cis 
(cytosolic) side can significantly decrease the bursting frequency and increase 
the mean closed time of RyR2 in a dose dependent manner (EC50=480 nM) (Fig. 
5A) (88). The binding of radio-labeled ryanodine ([3H]ryanodine) to RyR2s, which 
only happens when RyR2 is in the open state, is dampened by the appearance 
of 1 M sorcin at various [Ca2+]i concentrations (10
-4-10-7 M Ca2+), suggesting 
sorcin prevents open of RyR2s (Fig. 5B) (88). The onset of this inhibitory effect is 
less than 20ms, which enables sorcin to exert the inhibitory effect on RyR2s on a 
beat-to-beat basis (86). 
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Sorcin’s effect on SERCA 
Sorcin can increase the oxalate-facilitated 45[Ca2+]-uptake rate of SR vesicle in a 
dose dependent manner (EC50=520 nM), implying a stimulatory effect of sorcin 
on SERCA function. In accordance with this observation, SR Ca2+ load and 
decay rate of Ca2+ transient are significantly increased in adenovirus-mediated 
sorcin overexpression rat heart, reflecting higher SR Ca2+ pumping rate in 
appearance of sorcin (89). The exact binding site of sorcin to SERCA, however, 
is not determined yet. 
Sorcin’s effect on NCX 
The C-terminal Ca2+ binding domain of sorcin interacts with Ca2+ binding domain 
1 and 2 of NCX. The presence of Ca2+ binding domain of sorcin could 
significantly increase the NCX activity, suggesting the importance of this 
structure in the stimulation of NCX activity and formation of sorcin-NCX complex. 
The silence of sorcin in rabbit cardiomyocytes by sorcin mRNAi virus transfection 
leads to significantly lower INCX compared with control. Also, exogenous sorcin 
overexpressed in rabbit cardiomyocytes significantly increases INCX. These 
results suggest sorcin has stimulatory effect on NCX (90, 91).  
Sorcin’s effect on LTCC 
Sorcin is proposed to have direct interaction with 1c subunit of LTCC via its C-
terminal domain. (92). However the effect of sorcin on LTCC is complex and 
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controversial: while Meyers et al. find that sorcin accelerates Ca2+-dependent 
inactivation of ICa, leading to decreased ICa integral for a given membrane 
depolarization in mouse cardiomyocytes, Fowler et al. report that sorcin 
stimulates voltage-dependent inactivation but slows Ca2+-dependent inactivation 
in rabbit cardiomyocytes (87, 93). It seems that the regulation of sorcin on LTCC 
is influenced by prevailing recording conditions (use Ca2+ or Ba2+ as charge 
carriers; use HEK cells or ventricular cardiomyocytes).  
2.4 Sorcin’s role in e-c coupling in intact cardiomyocytes and whole heart 
The above in vitro experiments illustrate sorcin’s influence on four important proteins 
involved in cardiac e-c coupling: RyR2, LTCC, SERCA, and NCX. As RyR2 directly 
determines Ca2+ release from SR, it might be the most prominent molecular target of 
sorcin during e-c coupling. By influencing the pumping rate of SERCA and NCX, sorcin 
could alter the SR Ca2+ load, thus, indirectly influencing SR Ca2+ release. The alter of 
ICa inactivation by sorcin could change Ca
2+ entry, which may have further influences on 
[Ca2+]i, SR Ca
2+ release and SR Ca2+ load.  Due to the complex relationship between 
sorcin and its target proteins, sorcin’s overall effects on e-c coupling in intact 
cardiomyocytes remain unclear. Previous research tries to answer the question by using 
sorcin-overexpression animal or cardiomyocytes, but results are highly divergent. 
Suarez et al. claim a positive role of sorcin in maintaining heart contractility, as 
adenovirus-mediated 5-fold sorcin overexpression in mice significantly increases the 
contractility in normal hearts and rescues impaired contractility in diabetic heart (94). In 
 23 
 
support of this conclusion, Frank et al. find that adenovirus-mediated 1.7-fold sorcin 
overexpression in cultured cardiomyocytes and rat heart leads to increased peak force 
of contraction and fractional shortening (95). However, on the contrary, Farrell et al. find 
sorcin (3 M) dialysed into the cell via pipette significantly decreases Ca2+ transient 
amplitude and e-c coupling gain (ratio of Ca2+ transient amplitude to ICa) (86). Meyers el 
al. observe that the 20-fold sorcin overexpression mouse model decrease the Ca2+ 
transient amplitude compared with WT (87). Seidler et al. show adenovirus-mediated 
sorcin overexpression in rabbit cardiomyocytes leads to decreased Ca2+ transient 
amplitude and fractional shortening (90). Therefore, it seems that the method, time, and 
concentration used to expose sorcin to target proteins are critical determinants in the 
results obtained, and a high concentration of sorcin or its long-term exposure may be 
deleterious for cell function (94).  
2.5 Sorcin’s role in the development of heart diseases 
As Ca2+ triggers contraction of myofilaments, and plays a role in two hypertrophy-
related signaling pathways as second messenger, dysfunction of key Ca2+-handling 
proteins could break the delicate [Ca2+]i homeostasis and result in impaired heart 
contractility, hypertrophic cardiomyopathy, or arrhythmia (50, 96-100). Therefore, it is 
reasonable to suspect sorcin, a potent Ca2+ regulator during e-c coupling, can be an 
important factor in the development of heart diseases. Smith et al. and Matsumoto et al. 
find decreased sorcin expression in animal models of myocardial infarction and heart 
failure (89, 101). Meyers et al. observe that in mouse with spontaneous hypertensive 
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heart failure, the co-localization of sorcin with RyR2s at z-line is greatly disrupted (87). 
Moreover, a sorcin missense mutation, F112L, is found in two different families with 
familial hypertrophic cardiomyopathy and hypertension. Located at the end of D-helix, 
F112 residue is next to three crucial Ca2+ binding ligands in EF3, which are D113, D115 
and S117. The replacement of larger phenylalanine (7 carbons) to smaller leucine (4 
carbons) destabilizes EF3 and tilts EF1. As the result, sorcin with F112L mutation 
produces a 6-fold decrease of Ca2+-binding ability (102, 103) . In summary, the 
observations above imply sorcin dysfunction per se may associate with cardiac 
pathologies. However, it is still unknown whether sorcin dysfunction prevents or 
deteriorates the development of heart diseases. 
2.6 Summary 
By having RyR2, LTCC, NCX and SERCA as primary targets, sorcin helps to terminate 
Ca2+ release from the SR, and facilitates the re-uptake and extrusion of [Ca2+]i. Thus, 
we propose a role of sorcin as a cytosolic Ca2+ “sweeper” during e-c coupling. However, 
due to the limitations of research approaches, sorcin’s role in e-c coupling in intact 
cardiomyocytes and its role in heart function of normal and diseased hearts are still 
unknown. 
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Figure 4. Overall X-ray crystal structure of sorcin (81). (A) A sorcin monomer (left) consists of a 
glycine-rich N-terminal domain (red) and a C-terminal Ca
2+
 binding domain. The Ca
2+
 binding domain is 
endowed with five EF hands organized by eight -helices (A-H). EF1-3 (blue) have high Ca
2+
 (yellow) 
binding affinity. EF4-5 (green) have interaction of another sorcin and form a sorcin dimer structure (right). 
(B) The binding of Ca
2+
 to EF1-3 leads to a 21° shift of D helix away from the E-helix. EF1 and EF3 are 
widely opened in this situation, while EF2 displays minor movement.  
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Figure 5. Sorcin inhibits open of RyR2s (88). (A) Sorcin’s effect on single RyR2 inserted in artificial 
lipid bilayer. Recombinant sorcin added in the cis (cytosolic) side of the channel significantly decrease 
the open probability of RyR2. (B) Sorcin (1 M) significantly decreases the binding of 
3
[H]ryanodine to 
RyR2 at different Ca
2+
 concentrations. 
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CHAPTER III 
Using sorcin knockout mouse model to investigate the role of sorcin in e-c 
coupling in normal and diseased hearts 
3.1 Introduction 
Sorcin, a 21.6-kDa Ca2+ binding protein originally discovered in multi-drug resistance 
cells, is also expressed in ventricular cardiomyocytes of mammalian species, 
including humans (81, 104). We have found that the majority of sorcin is localized in 
bands of high intensity running along the width of the cardiomyocyte, interspaced at 
about ~1.7 µm, and overlapping with RyR2 located in z-lines (86, 87). Thus, a great 
portion of sorcin appears localized in the dyadic junction, where crucial steps of e-c 
coupling occur. Also, using single RyR2 channels or isolated ventricular cells, we 
have found that sorcin rapidly binds to RyR2 and directly inhibits single channel 
activity, translocates from soluble to membrane-bound protein targets in a Ca2+-
dependent manner, and attenuates Ca2+ sparks and Ca2+ transients in saponin-
permeabilized cardiomyocytes (86). By having RyR2s the as primary target, sorcin 
helps terminate Ca2+ release from the SR, and facilitates the re-uptake and extrusion 
of [Ca2+]i. Thus, we propose a role of sorcin as a cytosolic Ca
2+ “sweeper” during e-c 
coupling in ventricular myocytes. However, there are still two important questions 
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that remain to be answered. (1) How does sorcin influence e-c coupling in intact 
cells? As sorcin not only regulates RyR2 channels, but also influences Ca2+ entry 
and SR Ca2+ load by interacting with LTCC, SERCA2a and NCX, it is difficult to 
predict sorcin’s global effects in intact systems. Previous research attempted to 
answer this question by using sorcin-overexpressing animals or cardiomyocytes, 
however, this approach may not be optimal because the method, time, and 
concentration used to expose sorcin to target proteins are critical determinants of its 
function. Also, a high concentration of sorcin or its long-term exposure is shown to 
be detrimental for cell function (87, 90, 94, 95). Thus, an alternative model is desired 
to provide novel critical insight into the role of endogenous sorcin in e-c coupling and 
heart function; (2) What is sorcin’s role in the development of heart diseases? As 
Ca2+ triggers contraction of myofilaments, and is linked to  two hypertrophy-related 
signaling pathways as a second messenger, any dysfunction of key Ca2+-handling 
proteins will break the delicate [Ca2+]i homeostasis and result in impaired heart 
contractility, hypertrophic cardiomyopathy (99, 105), or arrhythmia. Therefore, it is 
reasonable to suspect sorcin, a potent Ca2+ regulator during e-c coupling, can be an 
important factor in the development of heart diseases. 
To investigate the role of sorcin in e-c coupling in intact cardiomyocytes and its role 
in the development of heart diseases, we have generated a sorcin knockout (sorcin 
KO) mouse by ablating the exon 3 of Sri, the sorcin-encoding gene (106, 107). The 
sorcin KO mouse model enables us to study the role of endogenous sorcin on e-c 
coupling in intact cardiomyocytes, and to mimic the sorcin loss-of-function mutations 
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found in patients/models with heart diseases (102). By subjecting the sorcin KO 
mice to acute and chronic stress, we could explore the role of sorcin in the 
development of some heart diseases and their underlying mechanisms. In the 
project, I am exploring: (1) whether the ablation of sorcin will alter the expression 
and function of other Ca2+ regulatory proteins, including RyR2, LTCC, NCX, and 
SERCA; (2) whether the ablation of sorcin will lead to increased spontaneous Ca2+ 
releases (Ca2+ sparks and Ca2+ waves), and whether the spontaneous Ca2+ releases 
could influence Ca2+ transient amplitude and trigger arrhythmogenic EADs and 
DADs in sorcin KO cardiomyocytes; (3) heart function and rhythm of sorcin KO mice 
in normal and stressed condition. 
3.2 Generation of sorcin KO mouse 
Sorcin KO mouse was generated by ablating the exon 3 of Sri, the sorcin-encoding 
gene (Fig. 6). Portions of the murine Sri were obtained by screening the 129SV 
CITB BAC library (Invitrogen Inc.). A DNA fragment of Sri exon 1, 2, 3, 4 was cloned 
into pBluescriptSK (Stratagene Inc.) that contained the MC1-HSV-TK cassette. To 
remove exon 3, which is present in both sorcin isoforms (accession no. 
NM_001080974.2 and NM_025618.3), a mini targeting vector containing a loxP-
flanked exon 3 and a loxP-flanked phosphoglycerol kinase (PGK) promoter-driven 
NEO-pGHpA cassette was generated. The mini targeting vector was transformed 
into the recombination-competent DY380 bacteria cells that previously transformed 
pBluescript-Sri-MC1-HSV-TK. Recombinants integrated the loxP-flanked exon 3 and 
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loxP-flanked pGK promoter-NEO-pGHpA cassettes were selected as targeting 
vectors. The homologous integration of the mini targeting cassette into pBluescript-
Sri-MC1-HSV-TK was confirmed by DNA sequencing. 
The targeting vector was electroporated into mouse 129S1/SvImJ ES cells. ES cells 
integrated the targeting vector were selected by growth on G18. Neor, GANCr 
clones were picked, expanded, and genomic DNA were isolated from each clone. 
Correctly targeted colonies, 1C4, 1D12, 1E1, 2B7, 2F5, 2H11, were identified by the 
appearance of a 2.6k-bp band by using the 32P autoradiogram 5’ probe. One 
euploid clone, 1D12, was microinjected into the blastocyst to produce a chimeric 
founder. The male chimera was mated with 129S1/SvImJ female (F0). The FloxNeo-
/+ mouse in F1 generation was selected to mate with EIIa-Cre transgenic mice to 
excise Neo cassette as well as Sri exon 3 (F2). Three primers: sorIn3Rev 5’-GAA 
GGC TGG CAT GGA GTG AAA GCA-3’, sorIn2For 5’-CTG ACC TCA GTC AAC 
CAG TAA GTA GG-3’, and Neo 5’-CGT TGG CTA CCC GTG ATA TT-3’ were used 
to determine genotyping of mice. 820-bp from Sri, which include exon 3 and 
neighboring introns, were excised by Cre-Lox recombination.  The excision of Sri 
exon 3 as well as Neo cassette was confirmed by a 453-bp band in PCR, which 
included a 3’ loxP site, a remnant 168-bp insertion from the targeting vector and 
neighboring intron, while WT DNA containing exon 3 presented a 1070-bp band (Fig. 
7A). The Sri+/- mice was backcrossed to 129S1/SvImJ mice for 10 generations to 
eliminate Cre recombinase. Finally two Sri+/- mice were crossed to get the Sri-/- mice. 
western blot using a sorcin antibody demonstrated complete absence of the 21.6 
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kDa sorcin band in sorcin KO hearts (Fig. 7B).  Crossbreeding of sorcin 
heterozygous mice yielded offspring with the expected Mendelian ratios of WT 
(sorcin 22%), heterozygous (sorcin 52%) and homozygous (sorcin 26%) mice. 
3.3 Acknowledgement 
Dr. Patricia Powers and Emily Farrell (Biotechnology Center of the University of 
Wisconsin) provided technical support for the generation of sorcin KO mouse colony. 
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Figure 6. Strategy for the generation of sorcin KO mice by homologous recombination. a. The 
sorcin targeting vector containing LoxP-flanked exon 3 of Sri, LoxP-flanked Neo-cassette and the 
HSV-TK cassette; b. WT Sri containing seven exons (four exons are shown in graph); c. Homologous 
recombination between the endogenous Sri and sorcin targeting vector results in a DNA carrying 
LoxP-flanked Sri exon 3 and Neo-cassette. d. Sorcin KO DNA is created by the Cre-excision of Sri 
exon 3 and Neo-cassette. 
 
 
 
 
 
 
Figure 7. Confirmation of sorcin KO mice. (A) PCR confirmation of WT and sorcin KO mice. Instead of 
the 1070-bp band seen in WT, a 453-bp band is detected in sorcin KO allele. (B) Western blot with sorcin 
antibody confirms the presence of sorcin in 3 WT hearts (first three bands) and its absence in 3 sorcin KO 
hearts.
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CHAPTER IV 
Arrhythmias and sudden death in sorcin KO hearts and mice under acute or 
chronic stress 
4.1 Introduction 
The crossbreeding of sorcin heterozygous mice yielded offspring with the expected 
Mendelian ratios of WT, heterozygous and homozygous mice, suggesting the ablation 
of sorcin is not lethal for embryonic development. However, the ablation of sorcin may 
lead to change of heart rhythm and heart function after the mice are born, as [Ca2+]i 
homeostasis is closely associated with heart rhythm and contractility (Chapter I, 1.6). To 
investigate the role of sorcin in heart function, in Chapter IV and V, I examined the heart 
structure, life span, electrocardiography (ECG), and heart contractility of sorcin KO mice. 
Considering the potential influence of age on heart function, both adult (6-month-old) 
and young (1-month-old) sorcin KO mice are used in the study. 
4.2 Normal structure of adult sorcin KO heart 
Vertical planes of hearts indicate no structural alterations in adult sorcin KO hearts 
compared with WT (Fig. 8). 
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4.3  Lower survival rate of freely-fed and stressed sorcin KO mice 
Lifespan of non-manipulated, freely-fed sorcin KO mice was shorter than WT littermates 
(18-month survival rate: KO 70% vs. WT 92.5%, N=40 in each group; Kaplan-Meier test 
p<0.05) (Fig. 9A), suggesting some problems of adaptation or fragile subsistence in the 
absence of sorcin. To assess whether the fragility of sorcin KO mice could be 
exacerbated by chronic stress, we conducted transverse aortic constriction (TAC) to 
induce pressure overload in adult mice (108). After surgery, the survival rate in sorcin 
KO mice was significantly lower than that of WT (KO 52% vs. WT 88% after 3 weeks, 
N=24 in each group, Kaplan Meier test p<0.01,) (Fig. 9B). The substantial difference in 
survival rate indicates that the fragility of sorcin KO mice is exacerbated by TAC 
4.4  Ventricular arrhythmias and sudden death in sorcin KO hearts and mice 
under acute or chronic stress 
As both freely-fed and TAC sorcin KO mice presented significantly lower survival rates 
than WT, we assessed whether cardiac arrhythmias were part of the underlying 
mechanisms leading to accelerated death. ECG of anesthetized adult mouse was 
recorded in control state and stressed state, which was induced by intraperitoneal 
injection of epinephrine 2 mg/kg + caffeine 120 mg/kg (109). Continuous recording of 
ECG activity showed that, whereas the WT group had few arrhythmic events, 5 out of 6 
adult sorcin KO mice presented higher incidence of premature ventricular contractions 
(PVCs), bidirectional ventricular tachycardia (BVT), and ventricular tachycardia (VT) 
within 5 min after injection (Fig. 10A-C). One third of sorcin KO mice, but no WT, 
experienced sudden cardiac arrest during recording (Fig. 10D). The duration of 
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ventricular arrhythmia was significantly longer in adult sorcin KO mice (356±151 s) than 
WT (16.6±6.9 s, p<0.05). (Fig. 10E), and two sorcin KO mice presented BVT for longer 
than 1000 s. In agreement with in vivo test, freshly explanted and Langendorff-perfused 
adult sorcin KO hearts displayed increased incidence of PVCs and bigeminy/trigeminy 
compared to WT hearts (Fig. 11).  
Like adult ones, young sorcin KO mice also presented a higher incidence of premature 
contractions, bigeminy, and bidirectional ventricular tachycardia than WT littermates 
(Fig. 12A-C). Nonetheless, unlike adult sorcin KO mice that presented stable, long-
lasting ventricular tachyarrhythmias (356±151 s), young sorcin KO mice presented short 
ventricular arrhythmia episodes (19.15±4.44 s, rank-sum test p<0.05 vs. adult ones). 
(Fig. 12D).  These results show that sorcin KO mice, while apparently normal under 
basal conditions, are thrown into ventricular arrhythmias under acute sympathetic 
stimulation and fare worse than WT when subjected to chronic stress.  Therefore, the 
shorter lifespan and increased TAC mortality of global sorcin KO mice may be due to 
cardiac alterations. 
4.5 Summary 
Sorcin KO mice were propagated at the expected Mendelian ratio, presented normal 
heart structure (Fig. 8), and had normal ECG as WT in resting condition. However, 
when under acute/chronic stress, sorcin KO hearts/mice presented high incidence of 
premature ventricular contractions, bidirectional ventricular tachycardia, ventricular 
tachycardia, and lower survival rate. Therefore, sorcin KO mice are in a delicate but 
precarious equilibrium under basal conditions. During -adrenergic stimulation, the 
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greatly enhanced kinetic of [Ca2+]i (Chapter I, 1.5) brakes the delicate equilibrium of 
sorcin KO mice, leading to arrhythmias and sudden death. Sorcin, a potent Ca2+ 
regulator, may play a prominent role in maintaining stable [Ca2+]i homeostasis in this 
situation. In the following study, I will investigate the change of [Ca2+]i homeostasis in 
sorcin KO cardiomyocytes and its correlation to ventricular arrhythmia.  
4.6 Acknowledgement 
This chapter includes data generated by Dr. Francisco Alvarado, University of Michigan 
(ECG recording) and Timothy Hacker, University of Wisconsin (TAC experiments). 
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Figure 8. Vertical planes of hearts indicate no structural alterations in sorcin KO heart compared 
with WT. Left: WT heart; right: sorcin KO heart. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9. Life span and survival rate of mice. (A) Long-term follow up of lifespan of sorcin KO and WT 
mice. N=40/group. Kaplan-Meier test p<0.05. (B) Survival rate of 6-montho-old mice after the conduction 
of transverse aortic constriction (TAC) N=24/group. Kaplan-Meier test p<0.01. 
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Figure 10. ECG recordings of 6-month-old anesthetized mice after the administration of 
epinephrine (2 mg/kg) + caffeine (120 mg/kg). (A) First trace: representative ECG of a WT mouse after 
5 min of injection; second trace: bidirectional ventricular tachycardia (BVT) in a sorcin KO mouse after 3 
min of injection; third trace: premature ventricular contractions (PVCs) in a sorcin KO mouse after 5 min of 
injection; fourth trace: ventricular tachycardia (VT) in a sorcin KO mouse after 3 min of injection. Each 
trace is 1s recording. (D) Percentage of mice that had ventricular arrhythmia after injection. (E) Number of 
ventricular arrhythmia episodes in WT and sorcin KO mice, per arrhythmia cocktail challenge. (F) 
Percentage of mice that presented sudden cardiac arrest after injection. (G) Duration of arrhythmias in 
WT and sorcin KO mice. N=6 in each group. ×, average value; *, p<0.05 vs. WT, #, p=0.051 vs. WT (t-test, 
rank-sum test,  test). 
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Figure 11. ECG and left ventricular pressure of 6-month-old mice recorded by Langendorff-
perfusion. (A-B) Representative ECG and left ventricular pressure of WT (A) and sorcin KO hearts (B) at 
basal condition and 1, 5, 8 min after isoproterenol perfusion. (C) Frequency of premature ventricular 
contraction (PVC). (D) Frequency of ventricular bigeminy/trigeminy. (E) Frequency of ventricular 
tachycardia. N=12 in each group. *, p<0.05 vs. WT (t-test, rank-sum test). 
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Figure 12. ECG recordings of 1-month-old anesthetized mice after the administration of 
epinephrine (2 mg/kg) + caffeine (120 mg/kg). (A) First trace: representative ECG of a WT mouse after 
injection; second trace: premature ventricular contractions in a sorcin KO mouse after injection; third 
trace: bigeminy in a sorcin KO mouse after injection; fourth trace: bidirectional ventricular tachycardia in a 
sorcin KO mouse after injection. (B) Percentage of mice that had ventricular arrhythmia after injection. (C) 
Number of ventricular arrhythmia episodes in WT and sorcin KO mice, per arrhythmia cocktail challenge. 
(D) Duration of arrhythmias in WT and sorcin KO mice. WT N=7, sorcin KO N=8. ×, average value; *, 
p<0.05 vs. WT (t-test, rank-sum test,  test). 
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CHAPTER V 
Contractility of sorcin KO hearts 
5.1 Introduction 
As discussed in Chapter I, [Ca2+]i homeostasis in cardiomyocytes is closely associated 
with heart contractility. For efficient heart contraction, synchronized Ca2+ release and 
quick Ca2+ sequestration during and after e-c coupling are desired. Therefore, heart 
contractility is greatly influenced by the activity of LTCC (determines Ca2+ entry), RyR2 
(determines SR Ca2+ release), NCX and SERCA (determine Ca2+ reuptake and 
extrusion). Spontaneous Ca2+ release events (Ca2+ sparks and Ca2+ waves), which 
happen during diastole due to RyR2-hyperactivity and/or SR Ca2+ overload, may also 
influence heart contractility by influencing SR Ca2+ load. As sorcin regulates Ca2+ entry 
(by regulating LTCC), Ca2+ release (by regulating RyR2s), and Ca2+ reuptake and 
extrusion (by regulating SERCA and NCX), it may play crucial role in maintaining heart 
contractility.  In this chapter, I evaluated the heart contractility of adult (6-month-old) and 
young (1-month-old) sorcin KO mice by Langendorff perfusion and echocardiographic 
recording. 
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5.2 Preserved heart contractility of 6-month-old sorcin KO mice 
Heart contractility was measured by Langendorff perfusion. Hearts from adult WT or 
sorcin KO mice were quickly excised and cannulated on a Langendorff-perfusion 
system via the aorta. Hearts were perfused with oxygenated KH solution at 37℃, the 
heart kept beating during recording. Left ventricular pressure was measured by a 
pressure transducer-connected balloon placed in the left ventricle (Fig. 13A). Under 
basal conditions, adult WT and sorcin KO hearts had comparable left ventricular 
developed pressure, systolic rate (maximum dp/dt) and diastolic rate (minimum dp/dt). 
When -adrenergic stimulation was triggered by adding 300 nM isoproterenol, a non-
selective β-adrenoreceptor agonist, in KH solution, both adult WT and sorcin KO heart 
presented significant increases in left ventricular developed pressure, systolic rate, and 
diastolic rate. As time passed, the contractility gradually went down to a steady level 
due to the adaptation of RyR2 to isoproterenol. However, the difference between adult 
WT and sorcin KO hearts before and after (for 10 mins) isoproterenol stimulation was 
not significant (Fig. 13B-E). 
Besides Langendorff perfusion, echocardiography was conducted to measure heart 
function (Fig. 14) of adult WT and sorcin KO mice before and after TAC surgery. LV 
mass, posterior wall (PW) thickness, anterior wall (AW) thickness, heart rate, stroke 
volume and fractional shortening were not significantly different between non-banded 
WT and sorcin KO mice (Fig. 14, non-banded). After TAC surgery, sorcin KO mice still 
presented comparable heart function as WT (Fig. 14, banded). 
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5.3 Decreased heart contractility of 1-month-old sorcin KO mice after 
isoproterenol stimulation 
Then I conducted Langendorff perfusion on 1-month-old WT and sorcin KO hearts. WT 
and sorcin KO hearts had comparable left ventricular developed pressure, systolic and 
diastolic rate under basal conditions. At the moment being stimulated by 300 nM 
isoproterenol, both WT and sorcin KO hearts presented enhanced contractility. However, 
young sorcin KO hearts gradually presented decreased contractility and slower diastolic 
rate than WT, and the difference was significant after ~5min of isoproterenol stimulation 
(Two-way RM ANOVA p<0.05 after 5 min of isoproterenol stimulation) (Fig. 15). 
5.4 Summary 
The Langendorff perfusion reveals that at early age (1-month-old), sorcin KO hearts 
have decreased contractility when under isoproterenol stimulation. However, as sorcin 
KO mice grow up, the impaired heart function was rescued by some compensatory 
mechanisms, so adult sorcin KO hearts presented comparable left ventricular 
developed pressure and systolic/diastolic rate as WT ones. To confirm the change of 
heart contractility in sorcin KO hearts at cellular level, I also measured Ca2+ transients 
and SR Ca2+ load of adult and young sorcin KO cardiomyocytes, which will be 
introduced in Chapter VIII. In following chapters, I will investigate the reason that leads 
to decreased heart contractility in young sorcin KO mice, and the possible 
compensatory mechanisms that rescue this deficiency. 
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Figure 13. Left ventricular pressure of 6-month-old WT and sorcin KO mice recorded by 
Langendorff perfusion. (A) A representative 3-secend-recording of left ventricular (LV) pressure. (B) 
Representative 15-min-recording of LV pressure traces of a 6-month-old WT (black) and a sorcin KO (red) 
heart.  Arrow indicates the time when isoproterenol reached the heart. (C) Left ventricular developed 
pressure (systolic pressure-end diastolic pressure) of Langendorff-perfused WT and sorcin KO hearts 
before (-5~0 min) and after (0~10 min) isoproterenol perfusion. (D-E) Systolic rate (maximum dp/dt) (D) 
and diastolic rate (minimum dp/dt) (E) of WT and sorcin KO hearts before and after isoproterenol 
perfusion. N=11 in each group (Two-way RM ANOVA). 
 
 
0
50
100
150
200
0
50
100
150
200
0
50
100
150
200
0
50
100
150
200
L
V
 p
re
s
s
u
re
 
  
  
(m
m
H
g
)
Iso
100s 100s
100s
6-month-old WT
1-month-old WT
6-month-old sorcin KO
L
V
 p
re
s
s
u
re
(m
m
H
g
)
1-month-old sorcin KO
100s
IsoIso
L
V
 p
re
s
s
u
re
 
(m
m
H
g
)
Iso
L
V
 p
re
s
s
u
re
(m
m
H
g
)
0
50
1 0
150
2 0
0
50
1 0
150
2 0
0
50
100
150
200
0
50
100
150
200
L
V
 p
re
s
s
u
re
 
  
  
(m
m
H
g
)
Iso
100s 100s
100s
6-month-old WT
1-month-old WT
6-month-old sorcin KO
L
V
 p
re
s
s
u
re
(m
m
H
g
)
1-month-old sorcin KO
1 0s
Iso
L
V
 p
re
s
s
u
re
 
(m
m
H
g
)
Iso
L
V
 p
re
s
s
u
re
(m
m
H
g
)
-5 0 5 10
0
2000
4000
6000
8000
10000
12000
-5 0 5 10
0
40
80
120
160
200
-5 0 5 10
-9000
-8000
-7000
-6000
-5000
-4000
-3000
-2000
-1000
 WT
 KOiso
M
a
x
 d
p
/d
t 
(m
m
H
g
/s
)
Time (min)
iso
L
e
ft
 v
e
n
tr
ic
u
la
r 
d
e
v
e
lo
p
e
d
 p
re
s
s
u
re
 (
m
m
H
g
)
Time (min)
M
in
 d
p
/d
t 
(m
m
H
g
/s
)
Time (min)
iso
-5 0 5 10
0
2 0
4 0
6 0
8 0
10 0
12 0
-5 0 5
0
40
80
120
160
200
-5 0 5 10
-9000
-8000
-7000
-6000
-5000
-4000
-3000
-2000
-1000
 WT
 KOiso
M
a
x
 d
p
/d
t 
(m
m
H
g
/s
)
Time (min)
iso
L
e
ft
 v
e
n
tr
ic
u
la
r 
d
e
v
e
lo
p
e
d
 p
re
s
s
u
re
 (
m
m
H
g
)
Time (min)
M
in
 d
p
/d
t 
(m
m
H
g
/s
)
Time (min)
iso
-5 0 5 10
0
2000
4000
6000
8000
1000
12000
-5 0 5 10
0
40
80
120
160
200
-5 0 5 10
-9000
-8000
-7000
-6000
-5000
-4000
-3000
-2000
-1000
 WT
 sorcin KO
iso
M
a
x
 d
p
/d
t 
(m
m
H
g
/s
)
Time (min)
iso
L
e
ft
 v
e
n
tr
ic
u
la
r 
d
e
v
e
lo
p
e
d
 p
re
s
s
u
re
 (
m
m
H
g
)
Time ( in)
M
in
 d
p
/d
t 
(m
m
H
g
/s
)
Time (min)
iso
-120-100 -80 -60 -40 -20 0 20 40 60 80
-0.4
-0.2
0.0
0.2
0.4
0.6
0.8
1.0
1.2 *
*
*
*
****
C
u
rr
e
n
t 
d
e
n
s
it
y
 
(p
A
/p
F
)
 WT
 sorcin KO
Voltage
A 
B 
C D E 
6- onth-old mice 
 
 45 
 
0
1
2
3
4
5
L
V
 m
a
s
s
/B
W
 (
m
g
/k
g
)
Banded
 
Non-banded
0
20
40
60
80
100
P
W
 t
h
ic
k
n
e
s
s
 (
%
)
BandedNon-banded
 
0
20
40
60
80
100
A
W
 w
a
ll
 t
h
ic
k
n
e
s
s
 (
%
)
BandedNon-banded
 
0
100
200
300
400
500
600
H
e
a
rt
 r
a
te
 (
b
e
a
ts
/m
in
)
BandedNon-banded
 
0
10
20
30
40
S
tr
o
k
e
 v
o
lu
m
e
 (
m
l/
m
in
)
BandedNon-banded
 
0
20
40
60
F
ra
c
ti
o
n
a
l 
s
h
o
rt
e
n
in
g
 (
%
)
bandedNon-banded
 
A B 
C D 
E F 
0
1
2
3
4
5
6
7
*
P
V
C
 f
re
q
u
e
n
c
y
 (
m
in
-1
)
 
*
0
1
2
3
4
5
B
ig
e
m
in
y
/t
ri
g
e
m
in
y
 f
re
q
u
e
n
c
y
(m
in
-1
) 
 
0.0
0.2
0.4
0.6
0.8
1.0
V
T
 f
re
q
u
e
n
c
y
 (
m
in
-1
) 
 
 WT
 sorcin KO
* 
* * 
* 
* 
* 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 14. Echocardiography measured heart function before (non-banded) and after TAC 
(banded). (A-F) Echocardiography measured LV mass (A), posterior wall (PW) thickness (B), anterior 
wall (AW) thickness (C), heart rate (D), stroke volume (E) and fractional shortening (F) before and after 
TAC. *, p<0.05 vs. non-banded hearts (t-test). 
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Figure 15. Left ventricular pressure of 1-month-old WT and sorcin KO mice recorded by 
Langendorff perfusion. (A) Representative 15-min-recording of LV pressure traces of a 1-month-old WT 
(black) and a sorcin KO (red) heart.  Arrow indicates the time when isoproterenol reached the heart. (B) 
Left ventricular developed pressure of Langendorff-perfused WT and sorcin KO hearts before (-5~0 min) 
and after (0~10 min) isoproterenol perfusion. (C-D) Systolic rate (maximum dp/dt) (D) and diastolic rate 
(minimum dp/dt) (E) of WT and sorcin KO hearts before and after isoproterenol perfusion. N=8 in each 
group. * p<0.05, ** p<0.01,  # p=0.051 (Two-way RM ANOVA). 
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CHAPTER VI 
Progressive electrophysiological remodeling in sorcin KO hearts 
6.1 Introduction 
In the Langendorff recording, 1-month-old sorcin KO hearts developed decreased 
contractility ~5 min after isoproterenol stimulation. However, this phenotype was 
rescued in adult sorcin KO hearts, suggesting the KO heart has developed 
compensatory mechanisms to respond to the ablation of sorcin. To test the hypothesis, 
we measured the expression and function of other proteins involved in e-c coupling in 
WT and sorcin KO cardiomyocytes, including LTCC, NCX, SERCA, and RyR2. 
6.2 Increased LTCC (Cav 1.2) and NCX expression in 6-month-old sorcin KO 
hearts 
We tested the expression of LTCC (by testing the Cav 1.2 subunit), NCX, SERCA, and 
RyR2 of hearts from WT and sorcin KO mice using western blots. NCX and LTCC 
(Cav1.2) were ~2.2-fold and 2.4-fold, respectively, increased in 6-month-old sorcin KO 
hearts compared to WT, while the expression of SERCA and RyR2 was unaltered (Fig. 
16A, B).  
Interestingly, 1-month-old sorcin KO hearts did not present overexpression of LTCC and 
NCX as adult hearts. Instead, the expression of NCX in young KO hearts was lower 
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than WT (p<0.05, N=5) (Fig. 16C, D). The difference is modest so we may need to 
increase the N number to confirm whether the difference is due to random variation. No 
other changes were noted.   
The result suggests that in response to the sorcin ablation, sorcin KO hearts develop a 
progressive overexpression of LTCC and NCX, which is observed in 6-month-old but 
not 1-month-old sorcin KO hearts. 
6.3 Increased NCX activity in 6-month-old sorcin KO cardiomyocytes 
To assess whether the overexpression of NCX and LTCC in 6-month-old sorcin KO 
hearts had a functional correlation, I measured NCX and LTCC activities respectively. 
NCX activity was first determined from the decay rate of the caffeine-induced Ca2+ 
transient (Kcaffeine). Cardiomyocytes were loaded with 10 μM Fluo-4 AM, a cell-
penetrating Ca2+ indicator with Ca2+ binding affinity (Kd) of 335 nM. Upon binding to 
Ca2+, the indicator presented an increase in fluorescence, which was excited at the 
wavelength of 488 nm and recorded at wavelength >505 nm. Ca2+ images were 
collected by the unidirectional line scan of the long axis of cell, at the speed of 3.072 
ms/line. The cardiomyocyte was paced by field stimulation for 20 times. After pacing, 10 
mM RyR2 agonist, caffeine, was quickly perfused to the cell. By fully opening RyR2, 
caffeine releases SR Ca2+ to cytosol and prevents Ca2+ accumulation in SR. In this 
situation, the decline of [Ca2+]i only depended on NCX, so the decay rate of caffeine-
induced Ca2+ transients can be used to evaluate the NCX activity (Fig. 17). In analysis, 
the decay of caffeine-induced Ca2+ transients (shown as F/F0) was fitted to the formula 
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𝐶𝑎(𝑡) = 𝐴 + 𝐶𝑎0 ∙ 𝑒
−
𝑡
𝜏, in which 𝐶𝑎0 was the apex of Ca
2+ transient. K, defined as 
1/was used to describe the pumping rate of NCX (KNCX).  
In recording, adult sorcin KO cardiomyocytes had comparable decay of caffeine-
induced Ca2+ transient as WT under basal conditions, but exhibited faster decay rate 
when under 300 nM isoproterenol stimulation (Fig. 18A, B). The calculated KNCX was 
significantly higher in sorcin KO cardiomyocytes under isoproterenol stimulation, 
reflecting faster NCX rate (Fig. 18C). 
To directly evaluate NCX activity, I recorded NCX current (INCX), which is generated by 
the exchange of 3 Na+ ions for 1 Ca2+ ion, by patch clamp. NCX current is the forward-
mode inward depolarizing current (Ca2+ out, Na+ in) at membrane potential lower than 
ENCX (ENCX=3ENa-2ECa, which is ~-60 mV in experiment setting), and turns to reverse-
mode (Ca2+ in, Na+ out) during depolarization. Cardiomyocytes were incubated in bath 
solution containing LTCC blocker (0.01 mM Nifedipine), Na+-K+-ATPase blocker (1 mM 
Ouabain∙8H2O), and Cl
- channel inhibitor (0.01 mM Niflumic Acid). Free [Ca2+]i was set 
at ~210 nM by adding 6 mM Ca2+ and 10 mM ethylene glycol-bis(β-aminoethyl ether)-
N,N,N',N'-tetraacetic acid (EGTA) in the pipette solution. The cell was depolarized to -40 
mV to inactivate INa and went through a ramp from +70 mV to -140 mV. After the first 
recording, the cell was perfused by 2.5 mM NiCl2 for 30 s, and went through the 
recording protocol again. NCX current—a Ni2+ sensitive current, was obtained by 
subtracting the second current from the first one (90, 91) (Fig. 19).  
Adult sorcin KO cardiomyocytes presented comparable INCX as WT under basal 
conditions (Fig. 20B). However, when under isoproterenol stimulation, sorcin KO 
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cardiomyocytes presented significantly larger outward (clamped at 50~80 mV) and 
inward (clamped at -120~-80 mV) INCX compared with WT (Fig. 20A, C). The increased 
KNCX as well as INCX in sorcin KO cardiomyocytes suggests that although the stimulatory 
effect of sorcin on NCX (90, 91) is not present in sorcin KO cells, NCX activity is 
enhanced under isoproterenol stimulation. It is likely that the overexpression of NCX 
protein detected by western blots allows for a more robust [Ca2+]i extrusion, resulting in 
enhanced NCX activity observed in isoproterenol-stimulated sorcin KO cardiomyocytes. 
6.4 Increased LTCC activity in 6-month-old sorcin KO cardiomyocytes 
I then measured L-type Ca2+ current (ICa) of 6-month-old sorcin KO and WT 
cardiomyocytes. Cardiomyocytes were incubated in bath solution containing 30 M INa 
inhibitor TTX and 10 mM Ito inhibitor 4-aminopyridine. The cell was clamped at -50 mV 
and depolarized from -50 mV to +70 mV with an increment of 10 mV. Under basal 
conditions, sorcin KO cardiomyocytes presented a modest but statistically significant 
increase in peak ICa compared to WT (Two-way RM ANOVA p<0.05) (Fig. 21, 23A). The 
robust stimulating effect of 300 nM isoproterenol blurred most of the difference in peak 
ICa, although at -20 mV sorcin KO cardiomyocytes still displayed significantly higher ICa 
than WT (Holm-Sidak test p<0.05) (Fig. 22, 23B). As ours and other group’s research 
have shown sorcin does not influence amplitude of ICa (86, 87), the increased peak ICa 
in sorcin KO cardiomyocytes corresponds to LTCC overexpression.  
Although ICa peak increased in adult sorcin KO cardiomyocytes under basal conditions, 
the Ca2+-dependent fast inactivation of ICa (fast) significantly accelerated at the same 
time (Fig. 24A, C) so the total ICa (ICa) was not significantly changed. On the other 
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hand, under isoproterenol stimulation,fast of ICa in adult sorcin KO cardiomyocytes was 
slower than that of WT, which favors more Ca2+ entry during e-c coupling (Fig. 24B, D).  
6.5 Unchanged NCX and LTCC activities in 1-month-old sorcin KO 
cardiomyocytes 
As 1-month-old sorcin KO hearts did not present overexpression of NCX and LTCC, I 
recorded INCX and ICa in 1-month-old cardiomyocytes to observe if NCX and LTCC still 
presented enhanced activities. Unlike adult cardiomyocytes, young sorcin KO 
cardiomyocytes did not present significant increase in INCX (Fig. 25) and ICa (Fig. 26) 
under basal conditions and isoproterenol stimulation. 
Although 1-month-old sorcin KO cardiomyocytes presented a slightly lower NCX 
expression than WT, and no longer had sorcin’s stimulatory effect on NCX, we did not 
observe a significant lower INCX in 1-month-old sorcin KO cardiomyocytes (although 
there was a tendency). This may because INCX in mouse cardiomyocytes is relatively 
small (~5 times smaller than rabbit cardiomyocytes) so subtle changes in current 
amplitude are hard to observe. However this does not influence our conclusion that the 
increased INCX and ICa observed in adult sorcin KO cardiomyocytes are due to protein 
overexpression 
6.6 Summary 
In experiment, we found adult, but not young sorcin KO hearts presented increased 
expression of LTCC and NCX, while the expression of RyR2 and SERCA were 
unaltered. In accordance with protein overexpression, NCX and LTCC activities were 
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significantly enhanced in adult, but not young sorcin KO hearts. The result suggests the 
enhanced LTCC/NCX activities observed in adult cardiomyocytes are more likely due to 
protein overexpression. Combining results of protein expression, current amplitude and 
Ca2+ decay rate, we postulate that the sorcin KO heart presents a progressive 
electrophysiological remodeling of ICa and INCX with increase of age. The increased Ca
2+ 
entry through LTCC and NCX (works in reverse mode to let Ca2+ in) during the upstroke 
of action potential could trigger more SR Ca2+ release and reload SR Ca2+, which may 
play a key role in rescuing the impaired contractility observed in young sorcin KO heart.  
6.7. Acknowledgement 
This chapter includes data generated by Dr. Francisco Alvarado, University of Michigan 
and Craig Weber, Department of Physiology, University of Arizona College of Medicine 
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Figure 16. Expression of Ca
2+
 regulatory proteins. (A-B) Representative western blots (A) and 
quantification (B) for sorcin, SERCA2a, RyR2, NCX, and LTCC expression in 6-month old WT and sorcin 
KO hearts. (C-D) Representative western blots (C) and quantification (D) for protein expression in 1-
month old WT and sorcin KO hearts. N=5 in each group. *, p<0.05 vs. WT; ** p<0.01 vs. WT (t-test). 
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Figure 17. Caffeine fully opens RyR2 and releases SR Ca
2+
 to cytosol. The cardiomyocyte was 
loaded by Fluo-4 AM and was paced by 1Hz field stimulation (arrow). After pacing, 10 mM caffeine was 
perfused to the cell to deplete SR Ca
2+
. The decay rate of caffeine-induced Ca
2+
 transient reflects NCX 
pumping rate. 
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Figure 18. NCX activity of 6-month-old cardiomyocytes evaluated by caffeine-induced Ca
2+
 
transient. (A-B). Representative Ca
2+
 imaging and plot of caffeine-induced Ca
2+
 transient of WT (A) and 
sorcin KO cardiomyocyte (B). WT caff= 2369 ms, KOcaff= 1758 ms. (C) NCX rate (KNCX) of WT and 
sorcin KO cardiomyocytes under basal conditions and isoproterenol stimulation. WT-basal n=10, KO-
basal n=9; WT-iso n=12, KO-iso n=13. *, p<0.05 vs. WT (t-test). 
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Figure 19. INCX recording. Upper: voltage protocol for recording INCX. Middle: Currents recorded before 
(black) and after (red) Ni
2+
 perfusion. Under: INCX obtained by subtracting the second current from the first 
one. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 20. INCX of 6-month-old WT and sorcin KO cardiomyocytes under basal conditions and 
isoproterenol stimulation. (A) representative INCX of WT and sorcin KO cardiomyocytes under 
isoproterenol stimulation. (B) I-V curve of INCX under basal conditions. WT-basal n=9, KO-basal n=8. (C) I-
V curve of INCX under isoproterenol stimulation. WT-iso n=9, KO-iso n=9. *, p<0.05 vs. WT (Two-way RM 
ANOVA). 
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Figure 21. ICa of 6-month-old WT and sorcin KO cardiomyocytes under basal conditions. (A-B) A 
representative recording of ICa of a WT cardiomyocyte (A) and a sorcin KO cardiomyocyte (B) under basal 
conditions.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 22. ICa of 6-month-old WT and sorcin KO cardiomyocytes under isoproterenol stimulation. 
(A-B) A representative recording of ICa of a WT cardiomyocyte (A) and a sorcin KO cardiomyocyte (B) 
under isoproterenol stimulation.  
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Figure 23. I-V curve of ICa of 6-month-old cardiomyocytes. (A) I-V curve of ICa of WT and sorcin KO 
cardiomyocytes under basal conditions. Two-way RM ANOVA p<0.05. (B) I-V curve of ICa of WT and 
sorcin KO cardiomyocytes under isoproterenol stimulation. WT-basal n=11, KO-basal n=14, WT-iso n=10, 
KO-iso n=10. *, Holm-Sidak test p<0.05 vs. WT; **, Holm-Sidak test p<0.01 vs. WT (Two-way RM 
ANOVA).  
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Figure 24. Inactivation of ICa of 6-month-old cardiomyocytes. (A) Representative curves of ICa at 0 mV 
under basal conditions. (B) Representative curves of ICa at -10 mV under isoproterenol stimulation. 
Currents are normalized to the peak value. (C) Ca
2+
-dependent inactivation (fast) of ICa inactivation at 0 
mV under basal conditions. (D) fast of ICa inactivation at -10 mV under isoproterenol stimulation. WT-basal 
n=11, KO-basal n=14, WT-iso n=10, KO-iso n=10. *, p<0.05 vs. WT (Rank-sum test). 
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Figure 25. I-V curve of INCX of 1-month-old cardiomyocytes. (A) I-V curve of INCX of WT and sorcin KO 
cardiomyocytes under basal conditions. (B) I-V curve of INCX of WT and sorcin KO cardiomyocytes under 
isoproterenol stimulation. WT-basal n=7, KO-basal n=8, WT-iso n=8, KO-iso n=7 (Two-way RM ANOVA).  
 
 
 
 
 
 
 
 
 
 
 
Figure 26. I-V curve of ICa of 1-month-old cardiomyocytes. (A) I-V curve of ICa of WT and sorcin KO 
cardiomyocytes under basal conditions. (B) I-V curve of ICa of WT and sorcin KO cardiomyocytes under 
isoproterenol stimulation. WT-basal n=11, KO-basal n=15, WT-iso n=10, KO-iso n=14 (Two-way RM 
ANOVA).  
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CHAPTER VII 
Ca2+ leak in sorcin KO cardiomyocytes  
7.1 Introduction 
As introduced before, the RyR2 is likely the most important target of sorcin. In single 
channel recordings, recombinant sorcin added in the cis (cytosolic) side can significantly 
decrease the bursting frequency and increase the mean closed time of RyR2 in a dose-
dependent manner (EC50 = 480 nM) (88). The onset of this inhibitory effect is fast (less 
than 20 ms), which enables sorcin to act on a beat-to-beat basis (86). Due to the 
inhibitory effect of sorcin on RyR2, sorcin (1 M) added in the bath solution is able to 
prevent Ca2+ sparks in permeabilized cardiomyocytes.  
In this chapter, I investigated whether endogenous sorcin in cardiomyocytes plays a role 
in decreasing SR Ca2+ leak by stabilizing RyR2s. Ca2+ sparks and RyR2-mediated 
diastolic Ca2+ leak flux were measured in sorcin KO cardiomyocytes. 
7.2 Ca2+ sparks in sorcin KO cardiomyocytes 
In resting cardiomyocytes, the stochastic release of Ca2+ from a CRU to a local area can 
be observed as a Ca2+ spark. Although random Ca2+ sparks are common in healthy 
cardiomyocytes, abnormal high frequency of Ca2+ sparks could lead to extra 
contractions and the depletion of SR Ca2+ load, which are detrimental to the heart 
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function. Therefore, the frequency and kinetics of Ca2+ sparks reflect RyR2 activity and 
cardiomyocyte stability. 
To record Ca2+ sparks, cardiomyocytes were loaded with 10 μM Fluo-4 AM. Ca2+ 
images were collected by the unidirectional line scan of the long axis of the cell, at a 
speed of 3.072 ms/line. The cell was paced at 1Hz by field stimulation for 20 times and 
then left in resting state for 20 s to observe Ca2+ sparks. For -adrenergic stimulation, 
300 nM isoproterenol was added in the bath solution. Ca2+ spark frequency = number of 
Ca2+ sparks ∙ cell width-1 ∙ time-1. 
Under basal conditions, both WT and sorcin KO cardiomyocytes had few Ca2+ sparks 
(KO 0.13±0.07 vs. WT 0.22±0.09 sparks/100 μm-1•s-1). Notably, however, sorcin KO 
cells exhibited significantly higher frequency of Ca2+ sparks under isoproterenol 
stimulation (KO 1.43±0.29 vs. WT 0.51±0.15 sparks •100 μm-1•s-1, p<0.05) (Fig. 27).  
I then evaluated the kinetics of Ca2+ sparks that appeared under isoproterenol 
stimulation. The amplitude of Ca2+ sparks was evaluated by normalizing the peak 
fluorescence (F) to background level (F0). Full width at half maximum (FWHM) was 
used to describe the spatial width of Ca2+ sparks. Full duration at half maximum (FDHM) 
was used to express the duration of the spark from rising to elimination, and half decay 
time was used to evaluate the decay rate of the spark. 
Sorcin KO cardiomyocytes presented no significant difference in FWHM compared with 
WT (KO 2.11±0.04 vs. WT 2.12±0.06 m, graph not shown). However, the spark 
amplitude, FDHM, and half decay time were all strikingly higher in sorcin KO 
cardiomyocytes compared with WT (p<0.001) (Fig. 28). The result suggests that RyR2s 
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in sorcin KO cardiomyocytes are more active, leading to increased Ca2+ spark 
frequency with greater spark amplitude and duration. 
7.3 Increased diastolic Ca2+ leak in sorcin KO cardiomyocytes 
Besides visible Ca2+ sparks, there is also diastolic SR Ca2+ leak flux in resting 
cardiomyocytes. The diastolic Ca2+ leak flux, together with a reversed SR Ca2+ pump 
back flux (110, 111), counteract forward Ca2+ uptake by SR Ca2+ pump, forming a 
pump-leak balance in cardiomyocytes (112, 113). To ascertain RyR2 activity without the 
influence of LTCC and NCX, I measured RyR2-mediated diastolic SR Ca2+ leak by an 
alternative method, as described by Shannon et al. (114). The cardiomyocyte was 
perfused with 0Na+-0Ca2+ solution (step 1), which blocked LTCC and NCX and stopped 
Ca2+ exchange between extracellular and intracellular compartments. Then, tetracaine 
(1 mM) was added to block RyR2 (step 2). As there was no longer SR Ca2+ leak flux 
through RyR2 after tetracaine perfusion, [Ca2+]i drops and [Ca
2+]SR increases until a new 
equilibrium state is achieved. The fluorescence difference between step 1 and 2 
reflected diastolic Ca2+ leak. At the end, 10 mM caffeine was perfused to the cell to 
measure SR Ca2+ load (Fig. 29A, B).  
Under basal conditions, sorcin KO cardiomyocytes had diastolic SR Ca2+ leak flux 
comparable to WT. However, under isoproterenol stimulation, sorcin KO 
cardiomyocytes displayed higher diastolic SR Ca2+ leak than WT (Fig. 29C). The 
difference was maintained after the Ca2+ leak was normalized to the SR Ca2+ load (Fig. 
29D). Isoproterenol stimulation decreased the diastolic Ca2+ leak flux in both WT and 
sorcin KO cardiomyocyte. This may be because PKA-mediated phosphorylation of 
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RyR2 accelerates adaptation of channel to Ca2+, leading to a lower Po after adaptation 
(38).  
7.4 Summary 
In this experiment, we found that sorcin KO cardiomyocytes presented increased Ca2+ 
sparks and diastolic Ca2+ leak flux. The Ca2+ leak in sorcin KO cardiomyocytes was still 
higher after being normalized to SR Ca2+ load (Fig. 29D), suggesting RyR2 hyperactivity 
in KO cells. This phenotype can only be observed in the presence of isoproterenol, 
suggesting sorcin’s Ca2+ regulatory effect is more prominent under -adrenergic 
stimulation (will be further discussed in Chapter IX and X). In the following experiments, 
I will investigate whether SR Ca2+ leak may trigger cell-wide Ca2+ waves in sorcin KO 
cardiomyocytes. 
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Figure 27. Ca
2+
 spark frequency in cardiomyocytes. (A) Representative recording of Ca
2+
 sparks of 
WT and sorcin KO cardiomyocytes under isoproterenol stimulation. Sparks were measured after 20 times 
of 1Hz pacing. (B) Ca
2+
 spark frequency of cardiomyocytes under basal conditions and isoproterenol 
stimulation. WT-basal n=16, KO-basal n=16, WT-iso n=16, KO-iso n=32 cells. *, p<0.05 vs. WT (t-test). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 66 
 
KO isoWT iso 0 Na
+
-0 Ca
2+
 
0 Na
+
-0 Ca
2+
 Tetracane
F/F
0
=0.5
5s
0 Na
+
-0 Ca
2+
500ms
7
0
.1
7
5

m
WT iso
7
0
.1
7
5

m
KO iso
0 Na
+
-0 Ca
2+
 Tetracane
0 Na
+
-0 Ca
2+
F/F
0
=0.5
5s
0 Na
+
-0 Ca
2+
Distance (m
)
Time
 (ms)
F
/F
0
0
10
20
30
***
***
H
a
lf
 d
e
c
a
y
 t
im
e
(m
s
)
 
0.0
0.5
1.0
1.5
2.0
2.5
***
S
p
a
rk
 a
m
p
li
tu
d
e
 (
F
/F
0
)
 
0
10
20
30
40
50
60
  WT
 sorcin KO
F
D
H
M
 (
m
s
)
 
A 
B C D 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 28. Kinetics of Ca
2+
 sparks. (A) 3D plots of representative Ca
2+
 sparks of WT and sorcin KO 
cardiomyocytes. (B-D) Ca
2+
 sparks amplitude (B), full duration at half maximum (FDHM) (C), and half 
decay time (D) under isoproterenol stimulation. WT-basal n=16, KO-basal n=16, WT-iso n=16, KO-iso 
n=32 cells. ***, p<0.001 (t-test). 
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Figure 29. RyR2-mediated diastolic Ca
2+ 
leak. (A-B) Representative plots of RyR2-mediated SR Ca
2+
 
leak of WT (A) and sorcin KO (B) cardiomyocytes under isoproterenol stimulation. Cardiomyocytes were 
perfused in 0Na
+
-0Ca
2+ 
solution. Then, tetracaine (1 mM) was added to block Ca2+ leak through RyR2. 
After 10s, tetracaine was washed out by 0Na
+
-0Ca
2+ 
solution. The fluorescence difference before and 
after tetracaine application (marked by red dashed line) reflects RyR-mediated diastolic Ca
2+
 leak. (C) 
RyR2-mediated diastolic SR Ca
2+
 leak under basal conditions and isoproterenol stimulation. (D) RyR2-
mediated diastolic SR Ca
2+
 leak normalized to SR Ca
2+
 load under basal conditions and isoproterenol 
stimulation. WT-basal n=11, KO-basal n=15; WT-iso n=12, KO-iso n=12 cells. *, p<0.05, **, p<0.01, ***, 
p<0.001 (t-test).  
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CHAPTER VIII 
Ca2+ transient amplitude and SR Ca2+ load in sorcin KO cardiomyocytes 
8.1 Introduction 
In Chapter VII, I found increased SR Ca2+ leak in sorcin KO cardiomyocytes, which put 
the cell at risk of having decreased SR Ca2+ load and Ca2+ transient amplitude. 
However, Langendorff perfusion experiments showed that 1-month-old, but not 6-
month-old sorcin KO mice, presented decreased heart contractility under isoproterenol 
stimulation (Chapter V). To investigate if there are corresponding changes in Ca2+ 
transient amplitude and SR Ca2+ load, I conducted Ca2+ imaging on 6-month and 1-
month-old sorcin KO cardiomyocytes.  
8.2 Preserved Ca2+ transient amplitude and SR Ca2+ load in 6-month-old sorcin KO 
cardiomyocytes 
Fluo-4 loaded cardiomyocyte was paced 20 times by 1Hz field stimulation, and 10 mM 
caffeine was perfused to the cell after pacing to deplete SR Ca2+ load. The amplitude of 
the Ca2+ transient was defined as the (F-F0)/F0 (F/F0) of the twitch Ca
2+
 transient, and 
SR Ca2+ load was F/F0 of caffeine-induced Ca
2+ transient (Fig. 30A). During pacing, 
Ca2+ transient amplitude gradually decreased until SR Ca2+ reached a steady level. The 
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average peak value of the last 10 Ca2+ transients of a train of stimulation was used to 
represent Ca2+ transient amplitude. 
Under basal conditions, 6-month-old sorcin KO cardiomyocytes presented modest but 
statistically higher Ca2+ transient amplitude than WT. Under isoproterenol stimulation, 
both WT and sorcin KO cardiomyocytes presented significantly increased Ca2+ transient 
amplitude, and there was no significant difference between the two groups (Fig. 30B). 
SR Ca2+ load, measured as caffeine-induced Ca2+ release after pacing, was not 
different between 6-month-old sorcin KO and WT cardiomyocytes (Fig. 30C). 
8.3 Decreased Ca2+ transient amplitude and SR Ca2+ load in 1-month-old sorcin 
KO cardiomyocytes 
I then measured Ca2+ transients and SR Ca2+ load of 1-month-old sorcin KO 
cardiomyocytes. 1-month-old sorcin KO cardiomyocytes had comparable Ca2+ transient 
amplitude and SR Ca2+ load as WT cells under basal conditions, but displayed 
significantly lower Ca2+ transient amplitude and SR Ca2+ load (p<0.001) under 
isoproterenol stimulation (Fig. 31). The result, at the cellular level, confirms that young 
sorcin KO heart has decreased contractility than WT under isoproterenol stimulation 
due to SR Ca2+ depletion. With increase of age, the phenotype is rescued such that no 
difference is observed between adult WT and sorcin KO hearts. 
8.4 Decreased SERCA pumping rate in sorcin KO cardiomyocytes 
To investigate the influence of SERCA activity on SR Ca2+ load, I evaluated SERCA 
pumping rate of 6-month-old sorcin KO cardiomyocytes by analyzing the decay of twitch 
 70 
 
[Ca2+]i transient.  The decay of twitch [Ca
2+]i (shown as F/F0) was fitted to the formula 
𝐶𝑎(𝑡) = 𝐴 + 𝐶𝑎0 ∙ 𝑒
−
𝑡
𝜏, in which 𝐶𝑎0 was the apex of the Ca
2+ transient. K, defined as 
1/was used to describe the decay rate of the Ca2+ transient. During pacing, the decay 
of the twitch [Ca2+]i transient depended on both NCX and SERCA, so KSERCA= Ktwitch− 
KNCX (115). KNCX was calculated by analyzing the decay of the caffeine-induced [Ca
2+]i 
transient,. 
Sorcin KO cardiomyocytes presented slower Ca2+ pumping rate by SERCA under 
isoproterenol stimulation (Fig. 32), which bodes well with previous results showing that 
sorcin stimulates SERCA function (89).  
8.5 Summary 
In this experiment, I found decreased Ca2+ transient amplitude and SR Ca2+ load in 1-
month-old sorcin KO cardiomyocytes under isoproterenol stimulation (Fig. 31). In 
accordance with the in vitro result, the left ventricular contractility of 1-month-old sorcin 
KO hearts was significantly lower than WT ~5 min after isoproterenol stimulation (Fig. 
15). The observation agrees with the hypothesis that the increased SR Ca2+ leak would 
bring negative effects on heart contractility.  
However, as sorcin KO mice entered into adulthood, 6-month-old sorcin KO 
cardiomyocytes presented modest but statistically higher Ca2+ transient amplitude than 
WT under basal conditions (Fig. 30B). The stroke volume and fractional shortening of 
adult sorcin KO heart, which were recorded by echocardiogram, presented a tendency 
of increase (Fig. 14E, F, non-banded) compared to WT (the Langendorff perfusion 
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cannot measure differences in contractility under basal conditions, as the baseline left 
ventricular pressure was manually set at ~70 mmHg by adjusting the size of the 
pressure balloon (Fig. 13). Under isoproterenol stimulation, 6-month-old sorcin KO 
cardiomyocytes did not present significant decrease in Ca2+ transient amplitude and SR 
Ca2+ load than WT (Fig. 30B), and KO hearts had comparable heart contractility as WT.  
Therefore, both in vivo and in vitro experiments demonstrate that there is impaired heart 
contractility in young sorcin KO mice but preserved contractility in adult mice. The 
observed phenomenon leads to the question: how Ca2+ transient amplitude and SR 
Ca2+ load are maintained in adult sorcin KO heart, even though there are increased 
spontaneous Ca2+ release events and decreased SERCA pumping rate? We believe 
that the electrophysiological remodeling of ICa and INCX may be important compensatory 
mechanisms. As the increased SR Ca2+ leak and decreased SERCA pumping 
eventually deplete SR Ca2+, sorcin KO cardiomyocytes become more dependent on 
external Ca2+ to activate contractions and reload the SR. Hence, sorcin KO cells must 
increase their pool and/or their activity of LTCC. The increased Ca2+ influx (Ca2+ in, Na+ 
out) through overexpressed NCX (Fig. 16, 18, 20) during the upstroke of the action 
potential also may contribute to maintaining SR Ca2+ release. Since a larger Ca2+ entry 
and SR Ca2+ leak cannot be sustained without a comparable Ca2+ extrusion 
mechanism, the 2.2-fold increase in the density of sarcolemmal NCX, who works in 
forward mode (Ca2+ out, Na+ in) during diastole, represents such concomitant Ca2+ 
extrusion mechanism. 
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Figure 30. Intracellular Ca
2+
 transients and SR Ca
2+
 load of 6-month-old sorcin KO cardiomyocytes. 
(A) Representative recordings of Ca
2+
 transients and SR Ca
2+
 load of WT and sorcin KO cardiomyocytes 
under basal conditions and isoproterenol stimulation. Cardiomyocytes were paced 20 times and 10 mM 
caffeine was perfused to the cell after pacing to measure SR Ca
2+
 load. (B-C) Ca
2+
 transient amplitude (B), 
SR Ca
2+
 load (C) of 6-month-old WT and sorcin KO cardiomyocytes under basal conditions and 
isoproterenol stimulation. WT-basal n=13, KO-basal n=14, WT-iso n=13, KO-iso n=16. *, p<0.05 vs. WT; 
***, p<0.001 (t-test). 
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Figure 31. Intracellular Ca
2+
 transients and SR Ca
2+
 load of 1-month-old sorcin KO cardiomyocytes. 
(A-B) Ca
2+
 transient amplitude (A) and SR Ca
2+
 load (B) of 1-month-old WT and sorcin KO 
cardiomyocytes under basal conditions and isoproterenol stimulation. Both WT and sorcin KO 
cardiomyocytes presented significant increase of Ca
2+
 transient amplitude and SR Ca
2+
 load after 
isoproterenol stimulation. WT basal n=12, KO basal n=8, WT iso n=14, KO iso n=13. ***, p<0.001 vs. WT 
(t-test). 
 
 
 
 
 
 
 
 
 
 
 
Figure 32. SERCA rate. SERCA rate of adult WT and sorcin KO cardiomyocytes under basal conditions 
and isoproterenol stimulation. WT-basal n=13, KO-basal n=14, WT-iso n=13, KO-iso n=16. *, p<0.05 vs. 
WT (t-test). 
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CHAPTER IX 
Prolonged action potential duration, early and delayed afterdepolarizations in 
adult sorcin KO cardiomyocytes 
9.1 Introduction 
It has been demonstrated that spontaneous Ca2+ sparks could trigger cell-wide Ca2+ 
waves, leading to -aftercontractions between two normal beatings (Chapter I, 1.6) (43). 
In accordance with this notion, 1-month and 6-month-old sorcin KO mice presented 
ventricular arrhythmias under acute stress, suggesting that the ablation of sorcin per se 
predisposes mice to arrhythmias. Nonetheless, young sorcin KO mice presented short 
ventricular arrhythmia episodes (19.15±4.44s), whereas adult sorcin KO mice presented 
stable, long-lasting ventricular tachyarrhythmias (356±151s, rank-sum test p<0.05 vs. 
young ones). Based on this observation, we propose that the electrophysiological 
remodeling of ICa and INCX, although could bring beneficial compensatory effects, may 
also provide a substrate for sustained ventricular arrhythmias because: 1) The 
enhanced inward INCX can lead to membrane depolarization and further, may trigger 
arrhythmogenic DADs if fired by spontaneous Ca2+ release events (116); 2) both 
increased ICa and INCX may prolong AP repolarization and induce early 
afterdepolarizations (EADs) (117, 118). To investigate if the electrophysiological 
remodeling described above brings about arrhythmogenic events in sorcin KO 
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cardiomyocytes, I recorded action potentials (APs) and Ca2+ transients simultaneously 
(119) in 6-month-old sorcin KO cardiomyocytes. 
9.2 Stochastic early afterdepolarizations and prolonged action potential duration 
in 6-month-old sorcin KO cardiomyocytes under basal conditions. 
Action potential and Ca2+ activities were recorded simultaneously by using the 
combined technique of patch clamp and confocal microscopy. In current clamp mode, 
action potentials were triggered by the 3-6 ms current injection of 400 pA at 1 Hz for 20 
times. 0.2 mM fluo-4 pentapotassium salt was dialysed into the cell via pipette solution 
to record Ca2+ activities simultaneously. Ca2+ images were collected by unidirectional 
line scan at the speed of 10 s/pixel. After pacing, the cell was left in resting state to 
observe spontaneous Ca2+ release events.  
Unlike the human cardiac action potential that presents a plateau phase during 
repolarization, the mouse cardiac action potential has a fast repolarization phase due to 
the strong effect of Ito (120) and other repolarizing currents. The APD of mice ventricular 
cardiomyocytes is around 100ms, which has important meaning to the fast heart rate in 
mice. Under basal conditions, cardiomyocytes had resting potential at around -70 mV. 
When stimulated by 1 Hz current injection, most (11 of 13) of WT cardiomyocytes 
presented normal triangle-shaped action potential, which triggered synchronized Ca2+ 
transients and cell contraction at 1 Hz frequency (Fig. 33).  
Under basal conditions, 8 out of 12 KO cardiomyocytes had normal APs and Ca2+ 
transients as WT. Four out of 12 sorcin KO cells presented EADs, which were 
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accompanied by spontaneous Ca2+ release events between pacing. However, because 
1 out of 11 WT cardiomyocytes also presented EADs, EAD frequency was not 
statistically different between sorcin KO and WT cardiomyocytes (p=0.128) (Fig. 34, 35).  
The APD was analyzed by measuring the time at which the membrane potential was 25, 
30, 50, 70, 75, 80, and 90 percentage repolarized. Among 12 sorcin KO cells, 6 had 
APD90 longer than 300 ms, including 4 that presented EADs and 2 that did not. The 
rest of 6 sorcin KO cells had APD90 that were less than 200 ms (Fig. 36). Although the 
variability of APD was large, the APD at 70, 75, 80, 90 percentage of repolarization 
were significantly increased in sorcin KO cells compared with WT (Two-way RM 
ANOVA p<0.001).  
In summary, most of sorcin KO cardiomyocytes presented normal APs and Ca2+ 
transients under basal conditions. Although some sorcin KO cardiomyocytes presented 
EADs and extremely long APD, the incidence did not reach statistical significance and 
so the KO mice did not present ventricular arrhythmias nor long Q-T interval at baseline 
(WT 0.0253±0.0042 vs. KO 0.0237±0.0034 s). Nonetheless, the phenomenon might be 
a sign of disturbed Ca2+ homeostasis in sorcin KO cardiomyocytes. 
9.3 Ca2+ waves, delayed afterdepolarizations and triggered activities in 6-month-
old sorcin KO cardiomyocytes under isoproterenol stimulation 
Under isoproterenol stimulation, sorcin KO cardiomyocytes had significantly higher 
frequency of spontaneous Ca2+ waves than WT. Seventy-eight percent (47/60) of 
spontaneous Ca2+ waves in sorcin KO cardiomyocytes led to membrane depolarizations 
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that were of sufficient amplitude to reach threshold for INa activation, thus triggering full-
blown DADs and synchronized full-cell-width Ca2+ transients, which were called 
triggered activities. By contrast, only 35% (6/17) of spontaneous Ca2+ waves developed 
into triggered activities in WT cardiomyocytes, while the rest only led to mild (<20 mV) 
membrane depolarization (Fig. 37). As sorcin KO cardiomyocytes had higher incidence 
of spontaneous Ca2+ waves, and their Ca2+ waves led to APs more readily, the 
frequency of triggered activities in sorcin KO cardiomyocytes was dramatically higher 
than WT (Fig. 38). 
Although sorcin KO cardiomyocytes had very few EADs during pacing under 
isoproterenol stimulation, they still presented significantly longer APDs at 70, 80, and 90 
percent of repolarization compared with WT (Fig. 39). 
9.4 Chelation of [Ca2+]i prevented triggered activities in sorcin KO cardiomyocytes 
To evaluate if [Ca2+]i is required to trigger EADs and DADs in sorcin KO cardiomyocytes, 
we added Ca2+ chelators in the pipette solution to buffer free [Ca2+]i. We first dialyzed 10 
mM 1,2-bis(o-aminophenoxy)ethane-N,N,N’,N’-tetraacetic acid (BAPTA) in cells, which 
completely quenched Ca2+-induced Ca2+ release in paced cells, and significantly 
decreased APD (Fig. 40, 41). Under isoproterenol stimulation, zero out of 7 sorcin KO 
cardiomyocytes dialyzed with BAPTA developed DADs (Fig. 40A, 42).  
We then tested the slower Ca2+ chelator, EGTA. EGTA also significantly decreased 
APD in sorcin KO cardiomyocytes (Fig. 41). Since the buffering rate of EGTA is ~100 
times slower than that of BAPTA, cells dialyzed with EGTA presented “Ca2+ spikes” 
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(121) of lower amplitude than normal Ca2+ transients when initially paced, and then 
decreased in amplitude later in time.  Resting [Ca2+]i slightly increased with pacing as 
the Ca2+-binding capacity of EGTA reached saturation. Among 8 cardiomyocytes 
dialyzed with EGTA, 3 presented DADs after pacing, which were accompanied with 
Ca2+ spikes (Fig. 40B, 42). The results suggests that [Ca2+]i is necessary to trigger 
electrical alterations in the sarcolemma of sorcin KO cardiomyocytes.  
9.5 Summary 
The electrophysiological remodelings, although beneficial in maintaining heart 
contractility, may alter the shape of the action potential and trigger focal activity. Under 
basal conditions, 6 out of 12 sorcin KO cardiomyocytes presented significantly 
prolonged APD 90, and 4 presented EADs (Fig. 35, 36). The significantly enhanced ICa 
in sorcin KO cardiomyocytes under basal conditions led to the prolongation of the action 
potential, which provided a favorable condition for the reactivation of ICa during the 
plateau phase of the action potential. Other factors, like reactivation of INa, may also 
contribute to the initiation of EADs (122). Although a fraction of sorcin KO 
cardiomyocytes had severe EAD events, the majority of KO cells presented normal AP 
and Ca2+ transients, so the incidence of EADs in sorcin KO cardiomyocytes was not 
significantly higher than that of WT (Fig. 35). Accordingly, sorcin KO mice did not show 
alteration in QT interval and arrhythmias under basal conditions. 
Under isoproterenol stimulation, resting sorcin KO cardiomyocytes presented increased 
Ca2+ sparks and Ca2+ waves due to RyR2-hyperactivity. As SERCA rate was decreased 
in sorcin KO cardiomyocytes, the contribution of NCX on [Ca2+]i extrusion increased. 
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The inward INCX, however, led to membrane depolarization that may trigger DADs. The 
increase of INCX in sorcin KO cardiomyocytes is [Ca
2+]i independent, as KO 
cardiomyocytes presented increased INCX when [Ca
2+]i of both WT and sorcin KO 
cardiomyocytes was set at 210 nM (Fig. 20). Thus, although WT cardiomyocytes also 
had some spontaneous Ca2+ release events under isoproterenol stimulation, the Ca2+ 
release-induced INCX was not large enough to depolarize the membrane potential to the 
threshold of firing (Fig. 37A). The complete quenching of Ca2+ propagation by the fast 
Ca2+ chelator, BAPTA, fully prevented DADs in sorcin KO cardiomyocytes, suggesting 
[Ca2+]i is prerequisite for triggering DADs in sorcin KO cells.  
The electrophysiological remodeling of adult sorcin KO cardiomyocytes provides a 
substrate for sustained ventricular arrhythmias. When spontaneous Ca2+ release events 
appear as a trigger, sorcin KO cardiomyocytes are more readily to have focal activities 
and DAD-induced ventricular arrhythmias. In accordance with the in vitro recording, 
adult sorcin KO mice presented long-lasting ventricular arrhythmias, cardiac arrest, and 
sudden death after the injection of an arrhythmogenic cocktail. Our project, for the first 
time, illustrates that the loss of sorcin is associated with lethal ventricular arrhythmias. 
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Figure 33. A representative recording of action potential and Ca
2+
 transient in a WT cardiomyocyte 
under basal conditions. Action potential was triggered by the 3-6ms current injection of 400pA at 1Hz 
for 20 times. 0.2 mM fluo-4 pentapotassium salt was dialysed into the cell via pipette solution to record 
Ca
2+
 activities. Upper panel: action potential; arrows indicate the time when the electrical stimulus was 
applied; middle panel: fluorescent recording of Ca
2+
 transient; under panel: line plot of Ca
2+
 transient. 
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Figure 34. Representative recordings of action potential and Ca
2+
 transient in sorcin KO 
cardiomyocytes under basal conditions. (A) A sorcin KO cardiomyocyte presented normal action 
potentials and Ca
2+
 transients under basal conditions. (B) A sorcin KO cardiomyocyte presented EADs, 
which were accompanied with spontaneous Ca
2+
 waves between pacing. APD was prolonged due to 
appearance of EADs. Arrows indicate the time when the electrical stimulus was applied. 
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Figure 35. EAD frequency of WT and sorcin KO cardiomyocytes under basal conditions and 
isoproterenol stimulation. WT-basal n=11, KO-basal n=12, WT-iso n=10, KO-iso n=14 (Rank-sum test). 
 
 
 
 
 
 
 
 
Figure 36. Action potential duration under basal conditions. (A) Scatter plot of APD90 under basal 
conditions. 6 of 12 sorcin KO cells presented APD 90 that was longer than 200ms. (F) APD at indicated 
percent of repolarization under basal conditions. WT-basal n=11, KO-basal n=12. *, p<0.05 vs. WT (Two-
way RM ANOVA). 
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Figure 37. Action potential and Ca
2+
 transients under isoproterenol stimulation. (A) Representative 
WT cardiomyocyte that presented spontaneous Ca
2+
 release events but not triggered activity after pacing. 
(B) Representative sorcin KO cardiomyocyte that presented triggered activities after pacing. Insert at right: 
expanded image of the spontaneous Ca
2+
 wave in the red frame, showing how a localized Ca
2+
 release 
(arrow) ignited a full Ca
2+
 transient and triggered activity. Arrows indicate the time when the electrical 
stimulus was applied. 
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Figure 38. Frequency of Ca
2+
 waves and triggered activities. (A) Frequency of spontaneous Ca
2+
 
waves in quiescent state. (B) Percentage of spontaneous Ca
2+
 waves that developed into triggered activity 
under isoproterenol stimulation: 3 out of 14 and 47 out of 60 spontaneous Ca
2+
 waves in WT and sorcin 
KO cardiomyocytes, respectively, developed into triggered activities. (C) Frequency of triggered activities 
in quiescent state. WT-basal n=11, WT-iso n=12, KO basal n=10, KO-iso n=14 cells. *, p<0.05 vs. WT; **, 
p<0.01 vs. WT (t-test, rank-sum test). 
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Figure 39. Action potential duration under isoproterenol stimulation. (A) Scatter plot of APD90 under 
isoproterenol stimulation. Each dot represents a different cell. (B) APD at indicated percent of 
repolarization under isoproterenol stimulation. WT-basal n=11, WT-iso n=12, KO basal n=10, KO-iso 
n=14 cells. *, p<0.05 vs (Two-way RM ANOVA).  
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Figure 40. Effects of Ca
2+ 
chelators on action potential and Ca
2+ 
transient. (A) Representative 
recording of action potential and Ca
2+ 
activity in a sorcin KO cardiomyocyte dialyzed with 10 mM BAPTA 
under isoproterenol stimulation. (B) Representative recording of action potential and Ca
2+
activity in a 
sorcin KO cardiomyocyte dialyzed with 10 mM EGTA under isoproterenol stimulation. Arrows indicate the 
time when the electrical stimulus was applied. 
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Figure 41. Effects of Ca
2+
 chelators on action potential duration. APDs of sorcin KO control, KO-
EGTA, and KO-BAPTA cardiomyocytes. KO-iso n=6, KO-iso + EGTA n=8, KO-iso + BAPTA n=7 cells. **, 
p<0.01 vs. KO-iso + EGTA and KO-iso + BAPTA cardiomyocytes (Two-way RM ANOVA). 
 
 
 
 
 
 
 
Figure 42. Percentage of cells that presented triggered activities under isoproterenol stimulation. 
KO-iso n=6, KO-iso + EGTA n=8, KO-iso + BAPTA n=7 cells. 
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CHAPTER X 
Discussion 
Sorcin, a 21.6-kDa Ca2+ binding protein originally discovered in multi-drug resistance 
cells, is also expressed in ventricular cardiomyocytes of mammalian species, including 
humans (81, 104). This basic observation compels a fundamental question: what does 
sorcin do in cardiac cells? We previously found that the majority of sorcin (but not all) is 
localized in bands of high intensity running along the width of the cardiomyocyte, 
interspaced at about ~1.7 µm, and overlapping with RyR2 located in z-lines (78). Thus, 
a great portion of sorcin appears localized in the dyadic junction, where crucial steps of 
e-c coupling occur. Using single RyR2 channel or isolated ventricular cells, we have 
found that sorcin rapidly binds to RyR2 and directly inhibits single channel activity. In 
cardiomyocytes, sorcin translocates from cytosol to membrane-bound protein targets in 
a Ca2+-dependent manner, and attenuates Ca2+ sparks and Ca2+ transients (86). These 
and other findings affirmed a role for sorcin in modulation of Ca2+ release by RyR2s, but 
its integral role in Ca2+ homeostasis and e-c coupling of the heart remained unclear. 
Here, we generated a mouse line with genetic ablation of Sri, the gene encoding for 
sorcin in humans and animal. These mice were born without heart structural remodeling, 
and propagated at the expected Mendelian ratio (Fig. 8). However, hearts of young (1-
month-old) sorcin KO mice, although showing no apparent electrical remodeling, quickly 
presented impaired contractility and transient tachyarrhythmias upon -adrenergic 
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stimulation (Fig. 12, 15), indicating that sorcin absence per se predisposes mice to 
decreased heart function and arrhythmias. As sorcin KO mice developed into adulthood, 
an increase in LTCC and NCX expression (Fig. 16) and activity (Fig.18, 20, 23) 
suggests cardiac contractions become increasingly dependent on sarcolemma Ca2+ 
entry and extrusion. Thus, the prolonged absence of sorcin plus its resultant electrical 
remodeling appears to lead the adult sorcin KO mice to a precarious condition, because 
a) stress tests promptly induced aberrant cardiac electrical activity (sustained ventricular 
tachyarrhythmias and sudden cardiac arrest) (Fig. 10, 11), b) at 7 months, their survival 
rate was lower than WT even under resting conditions (Fig. 9A), c) aortic banding that 
was tolerated by WT mice caused significantly more attrition in sorcin KO mice (Fig. 9B). 
All these results, therefore, support the hypothesis that sorcin is a relevant component 
of the e-c coupling machinery of the heart, independent of or in addition to other roles 
that it may play in other cells. 
10.1 Sorcin KO phenotype and resemblance to CPVT 
Sorcin ablation brings about significant alterations in Ca2+ homeostasis of ventricular 
myocytes, and this becomes more apparent under -adrenergic stimulation: isolated 
cardiomyocytes stimulated with isoproterenol displayed Ca2+ oscillations, 
aftercontractions, and DAD-elicited triggered activity (Fig. 37, 38), whereas SR Ca2+ 
leak and Ca2+ sparks were also especially increased under adrenergic stimulation (Fig. 
27, 28, 29). All these alterations are typically associated with hyperactive or “sensitized” 
RyR2 channels, and the general features of the sorcin KO phenotype are strikingly 
similar to those of CPVT, an arrhythmogenic syndrome linked to hyperactive RyR2 
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channels. In both cases, a cardiac phenotype is “silent” functionally and structurally and 
goes unnoticed until sympathetic stimulation triggers catastrophic Ca2+ release and life-
threatening arrhythmias. Bidirectional ventricular tachycardia, characteristic of Ca2+-
overloaded cells and a hallmark sign of CPVT (43), is also present in sorcin KO mice 
(Fig. 10, 12). We postulate, therefore, that RyR2 channels are among the most 
prominent molecular targets of sorcin and the most affected by its absence.  
10.2 Amplification of sorcin effect by sympathetic stimulation 
During normal -adrenergic stimulation, RyR2s are especially active due to increased 
ICa and higher SR Ca
2+ load. Ca2+ release from a cluster of RyR2s into the dyadic 
nanospace could theoretically increase local [Ca2+] to up to ~100 M(123, 124), which is 
sufficient to translocate sorcin to SR membrane targets. By decreasing RyR2 activity, 
sorcin conceivably attenuates Ca2+-induced Ca2+ release and helps prevent Ca2+-
triggered membrane depolarization. On the other hand, sorcin has been shown to be 
PKA-phosphorylated at residue S178 (80, 88, 89), and others (89) and we (unpublished 
data) have shown that phosphorylation facilitates translocation of sorcin from cytosolic 
to membrane compartments. Therefore, the high [Ca2+] in the dyadic space and sorcin 
phosphorylation during -adrenergic stimulation amplify sorcin’s regulatory effect on 
RyR2, its key target. 
10.3 Hypothesis for an integrated role of sorcin in e-c coupling 
While initial experiments to elucidate sorcin’s role in the heart demonstrate  that sorcin 
inhibits Ca2+ release by RyR2 channels, equally compelling are the findings that sorcin 
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increases NCX activity (90, 91), accelerates LTCC inactivation (87, 125), and stimulates 
SERCA2a Ca2+ uptake (89). All these effects are congruent with the general hypothesis 
that in normal ventricular myocytes, sorcin forms macromolecular complexes with at 
least four key players of e-c coupling, with its overall effect being that of a “cytosolic 
Ca2+ sweeper”.  By summing the individual effects exerted by sorcin on the above-
mentioned Ca2+ transporters, it seems obvious that the unified role for sorcin in cardiac 
cells is to restrict ICa-triggered RyR2 activity, prevent diastolic SR Ca
2+ leak, and avoid 
Ca2+ accumulation in cytosolic compartments.  However, what is not immediately 
obvious is that such an integrated effect is not possible in the long run, because it would 
eventually deplete cardiac cells of Ca2+ by restricting Ca2+ entry and release and 
stimulating Ca2+ extrusion. In a delimited and finely regulated system such as a 
ventricular cell, inward and outward Ca2+ fluxes must be equal, and in this zero-sum 
game, small disturbances are rapidly counteracted, lest profound alterations in electrical 
excitability, e-c coupling and signal conduction ensue (126). Therefore, a process that 
mitigates adrenergic-induced Ca2+ buildup is necessary, and we propose that sorcin is 
an integral part of such a process. Sorcin’s Ca2+ removal role may be especially active 
during β-adrenergic stimulation of the heart, right after cardiac cells have transitioned to 
Ca2+ overload due to a rapid surge of plasmalemmal Ca2+ entry. It is during this time 
window that Ca2+ fluxes are briefly unbalanced and cardiac cells are in a precarious 
equilibrium because the β adrenergic-induced Ca2+ overload, while maximizing 
contractions, promotes also the generation of DADs (by spontaneous Ca2+ release) and 
EADs (by prolonging APD). If removal of adrenergic-induced Ca2+ buildup by sorcin is 
indeed necessary, then sorcin KO mice should develop arrhythmias mainly during β-
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adrenergic stimulation, or under stress. In favor of this hypothesis, others and we find 
that adrenergic stimulation of ventricular cells increases translocation of sorcin from 
cytosolic to membrane-bound targets (89) and that sorcin KO hearts and living mice are 
readily thrown into tachyarrhytmias under sympathetic simulation. Besides preventing 
Ca2+ overload during systole, sorcin also prevents spontaneous Ca2+ leak during 
diastole. In the absence of sorcin, cardiomyocytes presented increased diastolic Ca2+ 
leak, which negatively affects SR Ca2+ and Ca2+ transient amplitude (1-month-old). 
Thus, the overall hypothesis that emerges from this and previous studies is that sorcin 
“sweeps” cytosolic compartments from excess Ca2+ during systole and diastole.   
10.4 General model to explain heart contractility and rhythm in young and adult 
sorcin KO mice  
From the above, we propose a model that integrates the major mechanisms governing 
the induction of arrhythmias/impaired heart contractility in young and adult sorcin KO 
mice. First, the model must consider fundamental differences in e-c coupling between 
immature (neonatal and young mice) and adult ventricular cells, with the former relying 
more on external Ca2+ entry due to incompletely formed T-tubules and dyads (127), 
while the latter obtaining from the SR (by CICR) most of the Ca2+ needed for 
contractions (29). Second, the model must also consider data showing increased LTCC 
and NCX density in adult, but not in young, sorcin KO cardiomyocytes, as observed 
here (Fig. 16). In both cases, however, β-adrenergic stimulation increases contractility 
by increasing Ca2+ cycling. Hence, in the absence of sorcin, a modulator that normally 
decreases Ca2+ entry, promotes Ca2+ extrusion, stimulates SR Ca2+ reuptake, and 
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decreases SR Ca2+ fluxes, the most plausible mechanism to induce ventricular 
arrhythmias in the immature hearts is one in which the adrenergically-stimulated 
cytosolic Ca2+ surges generate an inward depolarizing current of sufficient magnitude to 
bring membrane potential to threshold, generating DADs and subsequent triggered 
activity. This mechanism would be akin to that postulated to occur in CPVT (43) and 
does not require electrical remodeling (normal expression of e-c coupling proteins). On 
the other hand, abnormal expression of e-c coupling proteins in the mature sorcin KO 
hearts suggests gradual adaptation of the e-c coupling machinery to the absence of 
sorcin: the increased SR Ca2+ leak and decreased SERCA pumping may eventually 
depleting SR Ca2+, prompting sorcin KO cardiomyocytes to become more dependent on 
external Ca2+ to activate contractions and reload SR Ca2+. Hence, KO cells must 
increase their pool and/or their activity of LTCC (Fig. 16, 23). The increased Ca2+ influx 
(Ca2+ in, Na+ out) through overexpressed NCX (Fig. 16, 20) during the upstroke of 
action potential also makes contribution to maintaining SR Ca2+ release. Since a larger 
Ca2+ entry and SR Ca2+ leak cannot be sustained without a comparable Ca2+ extrusion 
mechanism, the 2.2-fold increase in the density of sarcolemmal NCX (Fig. 16), who 
works in forward mode (Ca2+ out, Na+ in) during diastole, represents such concomitant 
Ca2+ extrusion mechanism (Fig. 18, 20). In this hypothetical scheme, adult sorcin KO 
ventricular cells appear to tilt the balance between sarcolemmal and SR Ca2+ fluxes to 
maintain a pseudo-equilibrium that is stable under basal conditions but favors sustained 
ventricular arrhythmias under adrenergic stimulation (Fig. 43).  
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10.5 Limitations of our study and future plan 
Our general hypothesis above, while viable and accommodating of our major 
observations here, requires further testing and experimentation that go beyond the 
scope of this thesis. First, as it happens with most transgenic animals, ablation of a 
single gene seldom results in “clean” knockout of the target protein, because such 
targeted gene and protein interact with a variety of (known and unknown) partners that 
constitute an indivisible functional network. In the case of the sorcin KO, we performed 
a targeted analysis of what we considered the most relevant sorcin-interacting proteins 
and found alterations in some, but not all, binding partners.  Wider changes in protein 
expression would not be surprising, and they may even force key revisions of our 
hypothesis.  Second, sorcin is encoded by a single gene (Sri) and expressed in several 
tissues, therefore, it is possible that the cardiac arrhythmias or the decreased lifespan of 
sorcin KO mice reported here may have extra-cardiac origins. For example, we 
previously reported that the absence of sorcin in pancreatic β-cells triggers ER stress 
(77), and it is possible that the resultant glucose intolerance may have impacted cardiac 
function (128). Even though our experiments using isolated, Langendorff-perfused 
hearts indicate that cardiac arrhythmias are present in the absence of autonomic nerve 
system or hormonal input, we cannot completely discard this possibility. Lastly, the 
majority of sorcin localizes in immunocytochemical experiments to the dyadic space and 
near RyR2 (86, 87), but a small portion (~18%) does not. The first study describing 
expression of sorcin in cardiac cells (76) found anti-sorcin reactivity in mitochondria. 
The potential impact of mitochondria dysfunction to the cardiac arrhythmias described 
here, if any, requires an in-depth study of its own.    
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In the future, we would like to expand our scope to other potential target proteins of 
sorcin. A promising target could be Nav1.5, which is a member of the voltage-gated Na
+ 
channel family. Mutations in SCN5A, the encoding gene of Nav 1.5, are related to the 
long QT syndrome and Brugada syndrome. We would like to investigate whether sorcin 
has a direct interaction with Nav 1.5, and how this interaction may influence the 
membrane excitability and the action potential duration.  
Because part of sorcin is expressed in mitochondria, we are also interested in knowing 
the role of sorcin in mitochondria function. It has been demonstrated that the high 
concentration of mitochondria Ca2+ would trigger bursts of reactive oxygen species 
(ROS), named superoxide flashes, in the matrix of single mitochondria (129). Therefore, 
we would like to investigate whether sorcin, as a Ca2+ regulator, may influence 
mitochondrial ROS production and further induce heart diseases.     
10.6 Summary 
In summary, data here and published studies make it increasingly evident that sorcin 
modulates e-c coupling in the heart, at the very least through its well-established effect 
on RyR2 channels, but also through newly-found molecular targets. Although our 
general hypothesis may require further testing, data obtained here with the sorcin KO 
mouse does lay some solid foundations to postulate a unified role for sorcin in cardiac 
cells: sorcin is a Ca2+-dependent molecular switch that is activated during cytosolic Ca2+ 
surges, especially during -adrenergic stimulation and, by binding to at least four key e-
c coupling proteins, it removes Ca2+ from cytosolic compartments, guarantees efficient 
SR Ca2+ release, and avoids Ca2+-dependent arrhythmias (130).  
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Figure 43. General model to explain heart contractility and rhythm of young and adult sorcin KO 
mice. At early age of the sorcin KO mouse, the increased SR Ca
2+
 leak and decreased SERCA pumping 
eventually deplete SR Ca
2+
, leading to decreased heart contractility under isoproterenol stimulation. As 
time pass by, sorcin KO heart gradually develops electrophysiological remodeling of INCX and ICa, which 
helps preserving heart contractility. Although the ablation of sorcin per se could predispose mice to 
ventricular arrhythmias, the electrophysiological remodeling provides favorable substrate for DADs and 
EADs, leading to long-lasting ventricular arrhythmia, cardiac arrest and sudden death in adult sorcin KO 
mouse.  
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CHAPTER XI 
Materials and methods 
Generation of sorcin knockout mice   The generation of sorcin KO mice are 
described in Chapter III. Briefly, the sorcin KO targeting vector was generated by 
homologous recombination of endogenous Sri and a vector containing LoxP-flanked 
exon 3 of Sri and Neo-cassette. The targeting vector was electroporated into mouse 
129S1/SvImJ ES cells to generate a chimeric male founder. The excision of Neo 
cassette and Sri exon 3 was achieved by crossing FloxNeo-/+ mouse in F1 generation 
with EIIa-Cre transgenic mice. The Sri+/- mouse were backcrossed to 129S1/SvImJ mice 
for 10 generations to eliminate Cre recombinase and then used for breeding. Sorcin KO 
and their age-matched WT littermates were maintained and studied according to the 
protocol approved by the University Committee on Use and Care of Animals (UCUCA) 
and by the Association for Assessment and Accreditation of Laboratory Care 
International.  
Western blot    Whole heart homogenates were prepared as described before (35). 
Heart frozen in liquid nitrogen was pulverized by pestle, and homogenized in lysis buffer 
containing 0.9% NaCl, 10 mM Tris-HCl  pH 6.8, 20 mM NaF, 2 µM leupeptin, 100 µM 
phenylmethylsulphonyl fluoride, 500 µM benzamidine, 100 nM aprotinin at 4°C. The 
sample was centrifuged at 1000 xg for 10 minutes, and the supernatant was collected. 
The protein concentration was measured by Bradford method. For western blots, 50 µg 
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of lysate suspended in Laemmlii buffer was separated by SDS-PAGE in 4-20% TGX or 
AnyKD precast gels (Bio-Rad). Proteins were transferred to PVDF membranes at 25V 
for 16-18h at 4°C. Then, membranes were blocked in PBS-T containing (mM) 3 KH2PO4, 
10 Na2HPO4, 150 NaCl, pH 7.2–7.4, 0.1% Tween 20) plus 5% dried skim milk. Proteins 
were probed with the following primary antibodies: sorcin (1:2000 custom), SERCA 
(1:1000, ab2861, Abcam), NCX (1:200, ab6495, Abcam), Cav1.2 (1:200, ACC-003, 
Alomone), RyR2 (1:2000, MA3-925, ThermoFisher). After the membrane was washed 
three times by PBS-T, membranes were incubated with goat anti-mouse-HRP (1:1000, 
31437, Thermo) or goat anti-rabbit-HRP (1:2000, 31463, Thermo). Protein-antibody 
reactions were detected by using SuperSignal Femto ECL reagent (Thermo), and 
imaged by the ChemiDoc MP apparatus (Bio-Rad). Band intensity was analyzed by the 
ImageLab software (Bio-Rad). 
Translocation of endogenous sorcin   Translocation of endogenous sorcin was 
measured as described before (86). Briefly, isolated mouse cardiomyocytes were 
centrifuged for 2 min at 2,500 rpm. Cell pellets were collected and re-suspended in bath 
solution containing 0.01% saponin (to permeabilize the cell)  and 1 or 10 M Ca2+, with 
or without 300 nM isoproterenol. After ~1 min, cells were centrifuged for 5 min at 14,000 
rpm and the pellets were re-suspended in Ca2+-free bath solution.  The cell suspensions 
then went through glass fiber size C (GF-C) Whatman filter placed in a vacuum-
suctioned cell harvester. Membrane components were obtained by suspension of the 
filter in Laemmli buffer that contained (in mM): 250 Tris-HCl, 400 dithiothreitol,  8% SDS, 
0.04% bromphenol blue, 50% glycerol, pH=6.8. The protein suspension was subject to 
western blot for sorcin as described above. 
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Histological staining   Hearts explanted from mice were perfused with PBS and fixed 
in 10% neutral buffered formalin. Hearts were cut transversely, embedded in paraffin 
and stained with Masson’s trichrome. 
Mouse ventricular cell isolation   Mouse ventricular cells were isolated as described 
before (119). Mice of 5-6 months were anesthetized by peritoneal injection of urethane 
(1g/kg). After deep anesthetize was achieved, sternotomy was performed and the heart 
was quickly excised and cannulated on a Langendorff-perfusion system by aorta. The 
heart was first perfused with perfusion buffer containing (mM) 10 HEPES, 0.6 Na2HPO4, 
113 NaCl, 4.7 KCl, 12 NaHCO3, 0.6 KH2PO4, 1.2 MgSO4-7H2O, 10 KHCO3, 30 Taurine, 
500 mM 2,3-Butanedione monoxime, 5.5 mM Glucose, pH 7.46 at 37℃ at the speed of 
3ml/min. Then the heart was switched to digestion buffer which contained 773.48 u/ml 
Collagenase Type II, 0.14 mg/ml Trypsin, and 12.5 M CaCl2. After the heart turning 
soft, the ventricle was cut off from the heart and cut into pieces in the stopping buffer, 
which added 10% FBS and 12.5M CaCl2 in perfusion buffer. Tissue pieces were 
gently suspended and the single cell supernatant was transferred to a clean tube. Ca2+ 
was reintroduced to 1.0 mM step by step and cells were finally transferred to bath 
solution containing (mM) 135 NaCl, 4 KCl, 1.0 CaCl2, 1 MgCl2, 10 
Hepes, 1.2 NaH2PO4, and 10 glucose, pH 7.40 with NaOH. 
Confocal Ca2+ imaging   Ca2+ activities, including Ca2+ spark, field stimulation-
stimulated Ca2+ transient, SR Ca2+ load, and RyR2-mediated diastolic Ca2+ leak, were 
recorded by the LSM510 Meta inverted confocal microscope (Carl Zeiss) with a 40×/1.2 
N.A water immerse objective. Cardiomyocytes were incubated in bath solution with 
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10μM Fluo-4 AM at 37℃ for 5min, and then washed and kept in fresh bath solution. For 
-adrenergic stimulation, 300 nM isoproterenol was applied in bath solution. Ca2+ 
images were collected by the unidirectional line scan of the long axis of cell, at the 
speed of 3.072ms/line. Fluorescence was excited at the wavelength of 488 nm and 
recorded at wavelength >505 nm. For Ca2+ spark measurement, cardiomyocytes were 
paced 20 times by 1Hz field stimulation (54V, 2ms duration). After pacing, Ca2+ sparks 
were recorded in quiescent state for 10s. The criterion for the fluorescence amplitude of 
spark was set at 1.32 (F/F0). Ca
2+ spark frequency, full duration at half maximum 
(FDHM), full width at half maximum (FWHM), and half decay time were analyzed by a 
self-written program based on IDL 5.5. For Ca2+ transient and SR Ca2+ load, 
cardiomyocytes were paced 20 times by 1Hz field stimulation, and 10 mM caffeine was 
perfused to the cell after pacing to deplete SR. Ca2+ transient amplitude was defined as 
the (F-F0)/F0 (F/F0) of the twitch Ca
2+ transient, and SR Ca2+ load was F/F0 of 
caffeine-induced Ca2+ transient. The RyR2-mediated diastolic Ca2+ leak was measured 
as described before (114). Briefly, after pacing, the cardiomyocyte was perfused with 
0Na+-0Ca2+ solution containing (mM): 135 LiCl, 4 KCl, 1 MgCl∙6H2O,10 Hepes, 10 
EGTA, 10 Glucose, pH 7.40 with LiOH. As LTCC and NCX of the cardiomyocyte were 
blocked by 0Na+-0Ca2+ solution, there was no Ca2+ exchange between extracellular and 
intracellular environment (step 1). After 10s, solution was switched to 0Na+-0Ca2+ with 1 
mM RyR2 blocker tetracaine for 30s. Tetracaine blocked diastolic Ca2+ leak through 
RyR2 so the fluorescence difference between Step 1 and 2 reflected diastolic Ca2+ leak 
(step 2). Finally the cell was perfused with 10 mM caffeine to measure the SR Ca2+ load 
(Step 3). To evaluate NCX and SERCA activity, caffeine induced Ca2+ transient and 
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twitch Ca2+ transient were analyzed by the following method: The [Ca2+]i (shown as 
F/F0) is fitted to the formula 𝐶𝑎(𝑡) = 𝐴 + 𝐶𝑎0 ∙ 𝑒
−
𝑡
𝜏, in which 𝐶𝑎0 is the apex of Ca
2+ 
transient. K, defined as 1/is used to describe the decay rate of Ca2+ transient. During 
caffeine perfusion, Ca2+ continues to be released from the SR through open RyR2s so 
the decline of [Ca2+]i only depends on NCX, thus Kcaffeine=KNCX. In normal twitching, the 
decay of twitch Ca2+ transient depends on both NCX and SERCA, so KSERCA= Ktwitch-KNCX   
(115).  
For Ca2+ imaging with patch clamp, cardiomyocytes were dialyzed with 0.2 mM fluo-4 
pentapotassium salt via pipette solution. Ca2+ activity was recorded by the Olympus 
IX51 inverted microscopy system with a 40× oil immerse objective. Ca2+ images were 
collected by the unidirectional line scan at the speed of 10s/pixel. 
Patch clamp   Whole-cell patch clamp experiments were conducted by using an 
Axopatch 700B and a Digidata 1440A digitizer (Axon Instruments) at room temperature. 
For L-type Ca2+ current recording, cardiomyocytes were incubated in bath solution plus 
30 M TTX and 10 mM 4-aminopyridine to inhibit INa and Ito. The pipette solution 
contains (mM): 110 CsCl, 6 MgCl2, 5 Na2ATP, 0.3 Na2GTP, 10 Hepes, and 15 TEA∙Cl, 
pH 7.2 with CsOH. The cell was clamped at -50 mV and depolarized from -50 mV to 
+70 mV with an increment of 10 mV. For NCX current recording, cardiomyocytes were 
bathed in bath solution containing (mM) 130 NaCl, 5 CsCl, 1.2 MgSO4, 1.2 
NaH2PO4∙H2O, 10 Hepes, 10 Glucose, 0.01 Nifedipine, 1 Ouabain∙8H2O, 0.01 Niflumic 
Acid, 1.0 CaCl2, pH 7.40 with CsOH. Pipette solution contains (mM): 100 CsOH∙H2O, 
100 Glutamic Acid, 7.25 Na+-Hepes, 1 MgCl2.6H2O, 12.75 Hepes, 2.5 Na2ATP, 10 
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EGTA, 6 CaCl2.2H2O, pH 7.2 with CsOH. Once the whole-cell configuration formed, 
cardiomyocytes were perfused with bath solution. The cell was depolarized to -40 mV to 
inactivate INa and go through a ramp from +70 mV to -140 mV to induce remaining 
current. Then the perfusion solution was switched to bath solution plus 2.5 mM NiCl2 for 
30s, and the current recording protocol was repeated. NCX current—a Ni2+ sensitive 
current, was obtained by subtracting the second current from the first one. For action 
potential recording, cardiomyocytes were incubated in regular bath solution. The pipette 
solution contains (mM): 120 K-aspartate, 20 KCl, 1MgCl2, 4 Na2ATP, 0.1GTP, 10 
HEPES, 10 glucose, pH 7.2 with KOH. At current clamp mode, action potential was 
triggered by the 3-6ms current injection of 400 pA at 1Hz for 20 times, and Ca2+ 
transient was recorded by confocal microscopy at the same time. After pacing, the cell 
was left in quiescent state to observe DADs and Ca2+ waves for 10s. To quench Ca2+ 
release and propagation, 10 mM EGTA or 10 mM 5,5’-dibromo BAPTA tetrapotassium 
salt was added in pipette solution. When adding BAPTA in pipette solution, K-aspartate 
was adjusted to 80 mM. 
Electrocardiography   Mice were anesthetized by 5% isoflurane inhalation vaporized in 
oxygen at a flow rate of 0.8-1 L/min, and maintained at anesthetized state by 1.5-2% 
isoflurane. Mice were placed in a supine position on a heating pad of 37 ˚C, and needle 
ECG electrodes were placed under skin to record leads I and II ECG.  After 10 min of 
baseline ECG recording, acute stress will be induced by intraperitoneal injection of 
epinephrine 2 mg/kg + caffeine 120 mg/kg. ECG was analyzed as described before 
(Loaiza et al., 2013). After recording, mice were sacrificed by cervical dislocation. 
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Transverse aortic constriction   Transverse aortic constriction was conducted as 
described before (108). Briefly, mice were anesthetized by 5% isoflurane inhalation at 
the speed of 0.8-1 L/min, and maintained at anesthetized state by 1.5-2% isoflurane. 
During surgery, mice were kept ventilated at a respiration rate of 80-120/min, tidal 
volume 0.15ml. The transverse aorta was dissected, and a piece of 27½ gauge blunt 
needle was tied to transvers aorta by knots. Then, the needle was removed promptly to 
leave a 0.4 mm constriction. After surgery, mice were recovered in a clean cage with 
water and food, being monitored every 5-10 minutes and then returned to animal room. 
For analgesia, 5mg/kg Carprofen (Rimadyl) was administrated by i.p. injection 
preemptively and every 24 hours after surgery. 
Langendorff perfusion   Langendorff perfusion was conducted as described before 
(18). Briefly, the mouse was sacrificed by cervical dislocation, and the heart was quickly 
excised and cannulated on a Langendorff-perfusion system by aorta. The heart was 
perfused with 95% O2+5% CO2 gassed Krebs-Henseleit Buffer containing (mM): 118.5 
NaCl, 4.7 KCl, 1.2 KH2PO4, 1.2 MgSO4, 11 Glucose, 25 NaHCO3, 1.8 CaCl2.  A water-
filled balloon connected to the pressure transducer was placed in the left ventricle to 
record left ventricular pressure. Size of the balloon was adjusted to make the end 
diastolic pressure under basal conditions around 10 mmHg. Two electrodes were 
attached to the atria and apex of the heart to record ECG (AD Instruments, Colorado 
Springs, CO). After stabilization, ECG and left ventricular pressure of the heart were 
recorded at basal condition for 10min. Following, the heart was perfused with the KH 
solution containing 300 nM isoproterenol. ECG and left ventricular pressure under 
isoproterenol stimulation were recorded for another 10min. Arrhythmic behavior, end 
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diastolic left ventricular pressure, left ventricular developed pressure (maximum systolic 
pressure-end diastolic pressure), and max dp/dt were analyzed by LabChart 8. 
Echocardiography   Transthoracic echocardiography (Echo) was performed using a 
Vevo 2100 system with a 22-55 MHz transducer (MS550D; Visual Sonics), as described 
previously (35). Mice were anesthetized by 5% isoflurane inhalation at the speed of 0.8-
1 L/min, and maintained at anesthetized state by 1.5-2% isoflurane. Two-dimensionally 
guided M-mode images of the left ventricle (LV) were acquired at the tip of the papillary 
muscles. Posterior and anterior wall during systole and diastole, stroke volume, and 
heart rate were measured. Left ventricular mass was calculated by the formula [1.05 x 
((Posterior Walldiastole+Anterior Walldiastole+LV diameterdiastole)
3 – (LV diameterdiastole)
3 )]; 
fractional shortening was calculated by the formula [(LV diameterdiastole –LV 
diametersystole )/LV diameterdiastole] x 100.    
Statistics   All data are presented as mean±SEM.  Student t test, rank-sum test, two-
way repeated-measures ANOVA, Holm-Sidak test, 2 test, Kaplan-Meier test were 
carried when appropriate to determine statistical significance. p < 0.05 was considered 
statistically significant.
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